cpii_10q-3qfy09.htm
Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE
 COMMISSION
Washington, DC 20549
 
FORM 10-Q


(Mark One)
 
x
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended July 3, 2009
 
or
 
¨
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from ________ to ________
 
 
Commission file number: 000-51928

 
CPI INTERNATIONAL, INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
75-3142681
(I.R.S. Employer Identification No.)
811 Hansen Way, Palo Alto, California 94303
(Address of Principal Executive Offices and Zip Code)
(650) 846-2900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
 
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
 
Yes    x    No    ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
Yes    ¨    No    ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
¨
Accelerated filer
x
Non-accelerated filer
¨ (Do not check if a smaller reporting company)
Smaller reporting company
¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes ¨  No  x
 
 
APPLICABLE ONLY TO CORPORATE ISSUERS:
 
Indicate the number of shares outstanding for each of the registrant’s classes of Common Stock, as of the latest practicable date: 16,585,394 shares of Common Stock, $0.01 par value, at August 03, 2009.
 


 
 
 

and Subsidiaries
 
10-Q REPORT
INDEX
 
 
  4
       
 
  4
   
  4
   
  5
   
  6
   
  7
 
44
 
64
 
65
       
66
       
 
66
 
66
 
66
 
66
 
66
 
66
 
67
 
 
 
- 2 -

and Subsidiaries
 
 
Cautionary Statements Regarding Forward-Looking Statements
 
This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that relate to future events or our future financial performance. In some cases, readers can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially.
 
Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, which could cause actual results to differ materially from the results projected, expected or implied by the forward-looking statements. These risk factors include, without limitation, competition in our end markets; the impact of a general slowdown in the global economy; our significant amount of debt; changes or reductions in the United States defense budget; currency fluctuations; goodwill impairment considerations; customer cancellations of sales contracts; U.S. Government contracts laws and regulations; changes in technology; the impact of unexpected costs; the impact of environmental laws and regulations; and inability to obtain raw materials and components. All written and oral forward-looking statements made in connection with this report that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing risk factors and other cautionary statements included herein and in our other filings with the Securities and Exchange Commission (“SEC”). We are under no duty to update any of the forward-looking statements after the date of this report to conform such statements to actual results or to changes in our expectations.
 
The information in this report is not a complete description of our business or the risks and uncertainties associated with an investment in our securities. You should carefully consider the various risks and uncertainties that impact our business and the other information in this report and in our other filings with the SEC before you decide to invest in our securities or to maintain or increase your investment.
 
 
 
and Subsidiaries
 
 
Part I:  FINANCIAL INFORMATION
 
 
Item 1.              Unaudited Condensed Consolidated Financial Statements
 
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data – unaudited)

 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
Assets
           
Current assets:
           
Cash and cash equivalents
  $ 35,185     $ 28,670  
Restricted cash
    767       776  
Accounts receivable, net
    41,369       47,348  
Inventories
    68,900       65,488  
Deferred tax assets
    12,916       11,411  
Prepaid and other current assets
    4,382       3,823  
Total current assets
    163,519       157,516  
Property, plant, and equipment, net
    58,907       62,487  
Deferred debt issue costs, net
    3,923       4,994  
Intangible assets, net
    76,251       78,534  
Goodwill
    162,230       162,611  
Other long-term assets
    3,448       806  
Total assets
  $ 468,278     $ 466,948  
                 
Liabilities and stockholders’ equity
               
Current liabilities:
               
Current portion of long-term debt
  $ -     $ 1,000  
Accounts payable
    19,200       21,109  
Accrued expenses
    22,419       23,044  
Product warranty
    3,802       4,159  
Income taxes payable
    5,562       7,766  
Advance payments from customers
    12,355       12,335  
Total current liabilities
    63,338       69,413  
Deferred income taxes
    26,910       27,321  
Long-term debt, less current portion
    212,919       224,660  
Other long-term liabilities
    2,974       1,689  
Total liabilities
    306,141       323,083  
Commitments and contingencies
               
Stockholders’ equity
               
Common stock ($0.01 par value, 90,000 shares authorized; 16,792 and 16,538 shares issued; 16,586 and 16,332 shares outstanding)
    168       165  
Additional paid-in capital
    74,789       71,818  
Accumulated other comprehensive loss
    (1,725 )     (1,809 )
Retained earnings
    91,705       76,491  
Treasury stock, at cost (206 shares)
    (2,800 )     (2,800 )
Total stockholders’ equity
    162,137       143,865  
Total liabilities and stockholders' equity
  $ 468,278     $ 466,948  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
 
 
CONDENSED CONSOLIDATED
STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(In thousands, except per share data – unaudited)

 
   
Three Months Ended
   
Nine Months Ended
 
   
July 3,
2009
   
June 27,
2008
   
July 3,
2009
   
June 27,
2008
 
 Sales
  $ 82,520     $ 90,734     $ 241,569     $ 271,448  
 Cost of sales
    58,236       63,502       175,603       192,014  
 Gross profit
    24,284       27,232       65,966       79,434  
 Operating costs and expenses:
                               
 Research and development
    2,731       2,766       8,071       8,420  
 Selling and marketing
    4,762       5,012       14,552       15,512  
 General and administrative
    5,066       5,136       15,466       16,781  
 Amortization of acquisition-related intangible assets
    691       782       2,076       2,344  
 Net loss on disposition of fixed assets
    7       128       71       203  
 Total operating costs and expenses
    13,257       13,824       40,236       43,260  
 Operating income
    11,027       13,408       25,730       36,174  
 Interest expense, net
    4,204       4,627       12,965       14,244  
 (Gain) loss on debt extinguishment
    (51 )     121       (248 )     514  
 Income before income taxes
    6,874       8,660       13,013       21,416  
 Income tax expense (benefit)
    3,004       2,836       (2,201 )     6,928  
 Net income
  $ 3,870     $ 5,824     $ 15,214     $ 14,488  
                                 
 Other comprehensive income, net of tax
                               
Net unrealized gain (loss) on cash flow hedges and minimum pension liability adjustment
    3,346       1,268       84       (1,934
Comprehensive income
  $ 7,216     $ 7,092     $ 15,298     $ 12,554  
                                 
 Earnings per share - Basic
  $ 0.24     $ 0.36     $ 0.93     $ 0.88  
 Earnings per share - Diluted
  $ 0.22     $ 0.33     $ 0.87     $ 0.82  
                                 
 Shares used to compute earnings per share - Basic
    16,362       16,395       16,316       16,384  
 Shares used to compute earnings per share - Diluted
    17,577       17,669       17,428       17,719  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
 
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 (In thousands – unaudited)
 

   
Nine Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Cash flows from operating activities
           
Net cash provided by operating activities
  $ 20,308     $ 24,699  
                 
Cash flows from investing activities
               
Capital expenditures
    (2,349 )     (3,288 )
Proceeds from adjustment to acquisition purchase price
    -       1,615  
Payment of patent application fees
    -       (147 )
Net cash used in investing activities
    (2,349 )     (1,820 )
                 
Cash flows from financing activities
               
Purchases of treasury stock
    -       (1,800 )
Repayments of debt
    (12,358 )     (16,000 )
Proceeds from issuance of common stock to employees
    781       639  
Proceeds from exercise of stock options
    82       3  
Excess tax benefit on stock option exercises
    51       2  
Net cash used in financing activities
    (11,444 )     (17,156 )
                 
Net increase in cash and cash equivalents
    6,515       5,723  
Cash and cash equivalents at beginning of period
    28,670       20,474  
Cash and cash equivalents at end of period
  $ 35,185     $ 26,197  
                 
Supplemental cash flow disclosures
               
Cash paid for interest
  $ 9,742     $ 10,020  
Cash paid for income taxes, net of refunds
  $ 2,417     $ 9,846  
 
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(All tabular dollar amounts in thousands except share and per share amounts)
 
 
1.  
The Company and a Summary of its Significant Accounting Policies
 
The Company
 
Unless the context otherwise requires, “CPI International” means CPI International, Inc., and “CPI” means Communications & Power Industries, Inc. CPI is a direct subsidiary of CPI International. CPI International is a holding company with no operations of its own. The term “the Company” refers to CPI International and its direct and indirect subsidiaries on a consolidated basis.
 
The accompanying consolidated financial statements represent the consolidated results and financial position of CPI International, which is controlled by affiliates of The Cypress Group L.L.C. (“Cypress”). CPI International, through its wholly owned subsidiary, CPI, develops, manufactures and distributes microwave and power grid Vacuum Electron Devices (“VEDs”), microwave amplifiers, modulators, antenna systems and various other power supply equipment and devices. The Company has two reportable segments, VED and satcom equipment.
 
Basis of Presentation and Consolidation
 
The Company’s fiscal year is the 52- or 53-week period that ends on the Friday nearest September 30. Fiscal year 2009 comprises the 52-week period ending October 2, 2009 and fiscal year 2008 comprised the 53-week period ending October 3, 2008. The third quarters of both fiscal years 2009 and 2008 include 13 weeks. The first three quarters of both fiscal years 2009 and 2008 include 39 weeks. All period references are to the Company’s fiscal periods unless otherwise indicated.

The accompanying unaudited condensed consolidated financial statements of the Company as of July 3, 2009 and for the three and nine months ended July 3, 2009 are unaudited and reflect all normal recurring adjustments which are, in the opinion of management, necessary for the fair presentation of such financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended October 3, 2008. The condensed consolidated balance sheet as of October 3, 2008 has been derived from the audited financial statements at that date. The results of operations for the interim period ended July 3, 2009 are not necessarily indicative of results to be expected for the full year.
 
The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances, transactions and stockholdings have been eliminated in consolidation.

Foreign Currency Translation
 
The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. Gains or losses resulting from the translation into U.S. dollars of amounts denominated in foreign currencies are included in the determination of net income or loss. Foreign currency translation gains and losses are generally reported on a net basis in the caption “general and administrative” in the condensed consolidated statements of income and comprehensive income, except for translation gains or losses on income tax-related assets and liabilities, which are reported in “income tax expense (benefit)” in the condensed consolidated statements of income and comprehensive income.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Use of Estimates and Assumptions
 
 The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of sales and costs and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition; inventory and inventory reserves; provision for product warranty; business combinations; recoverability and valuation of recorded amounts of long-lived assets and identifiable intangible assets, including goodwill; recognition of share-based compensation; and recognition and measurement of current and deferred income tax assets and liabilities. The Company bases its estimates on various factors and information, which may include, but are not limited to, history and prior experience, experience of other enterprises in the same industry, new related events, current economic conditions and information from third-party professionals that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Revenue Recognition
 
Sales are recognized when persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed or determinable, and collectibility is reasonably assured. The Company’s products are generally subject to warranties, and the Company provides for the estimated future costs of repair, replacement or customer accommodation in cost of sales.
 
The Company has commercial and U.S. Government fixed-price contracts that are accounted for under American Institute of Certified Public Accountants Statement of Position No. 81-1, “Accounting for Performance of Construction-Type and Certain Production-Type Contracts.” These contracts are generally greater than one year in duration and include a significant amount of product development. The Company uses the percentage-of-completion method when reasonably dependable estimates of the extent of progress toward completion, contract revenues and contract costs can be made. The portion of revenue earned or the amount of gross profit earned for a period is determined by measuring the extent of progress toward completion using total cost incurred to date and estimated costs at contract completion.

Sales under cost-reimbursement contracts, which are primarily for research and development, are recorded as costs are incurred and include estimated earned fees in the proportion that costs incurred to date bear to total estimated costs. The fees under certain commercial and U.S. Government contracts may be increased or decreased in accordance with cost or performance incentive provisions that measure actual performance against established targets or other criteria. Such incentive fee awards or penalties are included in revenue at the time the amounts can be reasonably determined.
 
Revenue is recorded net of taxes collected from customers that are remitted to governmental authorities, with the collected taxes recorded as current liabilities until remitted to the relevant government authority.
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
2.  
Recently Issued Accounting Standards
 
In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value Measurements,” which defines fair value, establishes a framework for measuring fair value under other accounting pronouncements that permit or require fair value measurements, changes the methods used to measure fair value and expands disclosures about fair value measurements. In particular, disclosures are required to provide information on: the extent to which fair value is used to measure assets and liabilities; the inputs used to develop measurements; and the effect of certain of the measurements on earnings (or changes in net assets). SFAS No. 157 is effective for fiscal years beginning after November 15, 2007 and interim periods within those fiscal years. In February 2008, the FASB issued FASB Staff Position (“FSP”) SFAS No. 157-1, “Application of FASB Statement No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement under Statement 13,” which removes certain leasing transactions from the scope of SFAS No. 157 and FSP SFAS No. 157-2, “Effective Date of FASB Statement No. 157,” which defers the effective date of SFAS No. 157 for one year for certain nonfinancial assets and nonfinancial liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis. Effective October 4, 2008, the Company adopted SFAS No. 157 for financial assets and liabilities recognized at fair value on a recurring basis. The adoption of SFAS No. 157 did not have a significant impact on the Company’s consolidated financial statements, and the resulting fair values calculated under SFAS No. 157 after adoption were not significantly different than the fair values that would have been calculated under previous guidance. See Note 4 for further details on the Company’s fair value measurements.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities - Including an amendment of FASB Statement No. 115.” SFAS No. 159 permits companies to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. The objective of SFAS No. 159 is to provide opportunities to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply hedge accounting provisions. SFAS No. 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The Company adopted SFAS No. 159 effective October 4, 2008. The Company currently does not have any instruments for which it has elected the fair value option under SFAS No. 159. Therefore, the adoption of SFAS No. 159 has not impacted the Company’s consolidated financial position, results of operations or cash flows.

In December 2007, the FASB issued SFAS No. 141 (revised 2007), or 141(R), “Business Combinations,” which replaces SFAS No. 141. SFAS No. 141(R) establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any non-controlling interest in the acquiree and the goodwill acquired. The Statement also establishes disclosure requirements which will enable users to evaluate the nature and financial effects of the business combination. SFAS No. 141(R) is effective for fiscal years beginning after December 15, 2008. The Company will be required to adopt SFAS No. 141(R) in its fiscal year 2010 commencing October 3, 2009.
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133.” SFAS No. 161 requires enhanced disclosures about an entity’s derivative instruments and hedging activities including: (1) how and why an entity uses derivative instruments; (2) how derivative instruments and related hedged items are accounted for under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” and its related interpretations; and (3) how derivative instruments and related hedged items affect an entity’s financial position, financial performance and cash flows. SFAS No. 161 is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with earlier application encouraged. The Company adopted SFAS No. 161 in the second quarter of fiscal year 2009. Since SFAS No. 161 only required additional disclosure, the adoption did not have an impact on the Company’s consolidated financial position, results of operations or cash flows. See Note 6 for further details on the Company’s derivative instruments and hedging activities.

In October 2008, FASB issued FSP No.132 (R)-1, “Employers’ Disclosures about Pensions and Other Postretirement Benefits,” to require that an employer disclose the following information about the fair value of plan assets: (1) the level within the fair value hierarchy in which fair value measurements of plan assets fall; (2) information about the inputs and valuation techniques used to measure the fair value of plan assets; and (3) a reconciliation of beginning and ending balances for fair value measurements of plan assets using significant unobservable inputs. The final FSP will be effective for fiscal years ending after December 15, 2009, with early application permitted. The Company will be required to adopt FSP No.132 (R)-1 in its fiscal year 2010 commencing October 3, 2009. At initial adoption, application of the FSP would not be required for earlier periods that are presented for comparative purposes. The Company is currently evaluating the potential impact of adopting this FSP on the disclosures in its consolidated financial statements.

In April 2009, the FASB issued FSP SFAS No. 141R-1, “Accounting for Assets Acquired and Liabilities Assumed in a Business Combination That Arise from Contingencies.” FSP SFAS No. 141R-1 amends the provisions in SFAS No. 141R, “Business Combinations,” and requires an acquirer to recognize at fair value, at the acquisition date, an asset acquired or a liability assumed that arises from a contingency if the acquisition date fair value of that asset or liability can be determined during the measurement period. If the acquisition date fair value cannot be determined during the measurement period, an asset or liability shall be recognized at the acquisition date if (1) information available before the end of the measurement period indicates that it is probable that an asset existed or that a liability had been incurred at the acquisition date, and (2) the amount of the asset or liability can be reasonably estimated. FSP SFAS No. 141R-1 is effective for contingent assets and contingent liabilities acquired in business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. The Company will apply the provisions of FSP SFAS No. 141R-1 if and when a future acquisition occurs.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

In April 2009, the FASB issued FSP SFAS No. 157-4, “Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly,” which provides additional guidance in evaluating certain factors that are indicative of a significant decrease in the volume and level of activity for an asset or liability when compared to normal market activity. Additionally, this statement clarifies the circumstances to consider when evaluating whether a transaction is not orderly, in which quoted prices may not be determinative of fair value. FSP SFAS No. 157-4 is applied prospectively to all fair value measurements where appropriate and is effective for interim and annual periods ending after June 15, 2009. The Company adopted the provisions of FSP SFAS No. 157-4 effective April 4, 2009. The adoption of FSP SFAS No. 157-4 did not have an impact on the Company’s results of operations and financial position.

In April 2009, the FASB issued FSP SFAS No. 107-1 and Accounting Principles Board (“APB”) No. 28-1, “Interim Disclosures about Fair Value of Financial Instruments.” FSP SFAS No. 107-1 and APB No. 28-1 amend FASB Statement No. 107, “Disclosures about Fair Value of Financial Instruments,” to require disclosures about fair value of financial instruments for interim reporting periods of publicly traded companies as well as in annual financial statements. FSP FAS No. 107-1 and APB No. 28-1 is effective for interim reporting periods ending after June 15, 2009. The Company’s disclosures about fair value of financial instruments in the third quarter of fiscal year 2009 reflect the adoption of this FSP. Since FSP FAS No. 107-1 and APB No. 28-1 only requires additional disclosures, the adoption did not have an impact on the Company’s consolidated financial position, results of operations or cash flows. See Notes 4 and 5.

In May 2009, the FASB issued SFAS No. 165, “Subsequent Events,” which provides guidance to establish general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. In particular, this statement sets forth: (1) the period after the balance sheet date during which management of a reporting entity should evaluate events or transactions that may occur for potential recognition or disclosure in the financial statements; (2) the circumstances under which an entity should recognize events or transactions occurring after the balance sheet date in its financial statements; and (3) the disclosures that an entity should make about events or transactions that occurred after the balance sheet date. SFAS No. 165 is effective for interim or annual financial periods ending after June 15, 2009. The Company adopted the provisions of SFAS No. 165 in the third quarter of fiscal year 2009. The Company evaluated all events or transactions that occurred from July 4, 2009 through August 12, 2009, the date the Company issued these financial statements. During this period, the Company did not have any material recognizable or non recognizable subsequent events.
 
In June 2009, the FASB issued SFAS No. 166, “Accounting for Transfers of Financial Assets and amendment of FASB Statement No. 140.” This statement was issued to improve the relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial statements about a transfer of financial assets; the effects of a transfer on its financial position, financial performance and cash flows; and a transferor’s continuing involvement, if any, in transferred financial assets. This statement is effective for the first annual reporting period that begins after November 15, 2009. The application of this statement will only apply and be effective should the Company transfer financial assets after October 2, 2010. The adoption of this statement is not expected to have a material effect on the Company’s results of operations, financial position or cash flows.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
In June 2009, the FASB issued SFAS No. 168, “The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles.” This standard replaces SFAS No. 162, “The Hierarchy of Generally Accepted Accounting Principles,” and establishes only two levels of U.S. generally accepted accounting principles (“GAAP”), authoritative and nonauthoritative. The FASB Accounting Standards Codification (the “Codification”) will become the source of authoritative, nongovernmental GAAP, except for rules and interpretive releases of the Securities and Exchange Commission (“SEC”), which are sources of authoritative GAAP for SEC registrants. All other non-grandfathered, non-SEC accounting literature not included in the Codification will become nonauthoritative. This standard is effective for financial statements for interim or annual reporting periods ending after September 15, 2009. The Company will begin to use the new guidelines and numbering system prescribed by the Codification when referring to GAAP in the fourth quarter of fiscal year 2009. As the Codification was not intended to change or alter existing GAAP, it will not have any impact on the Company’s results of operations, financial position or cash flows.
 
 
3.           Supplemental Balance Sheet Information
 
Accounts Receivable:  Accounts receivable are stated net of allowances for doubtful accounts as follows:
 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
Accounts receivable
  $ 41,475     $ 47,437  
Less: Allowance for doubtful accounts
    (106 )     (89 )
Accounts receivable, net
  $ 41,369     $ 47,348  

Inventories:    The following table provides details of inventories, net of reserves:
 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
Raw material and parts
  $ 38,173     $ 40,187  
Work in process
    22,134       17,622  
Finished goods
    8,593       7,679  
    $ 68,900     $ 65,488  

Reserve for excess, slow-moving and obsolete inventory:    The following table summarizes the activity related to reserves for excess, slow-moving and obsolete inventory:
 
   
Nine Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Balance at beginning of period
  $ 9,860     $ 9,784  
Inventory provision, charged to cost of sales
    818       988  
Inventory write-offs
    (1,036 )     (1,619 )
Balance at end of period
  $ 9,642     $ 9,153  

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Reserve for loss contracts:   The following table summarizes the activity related to reserves for loss contracts:
 
   
Nine Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Balance at beginning of period
  $ 1,928     $ 2,700  
Provision for loss contracts, charged to cost of sales
    2,696       1,932  
Credit to cost of sales upon revenue recognition
    (1,522 )     (2,702 )
Balance at end of period
  $ 3,102     $ 1,930  

Reserve for loss contracts are reported in the condensed consolidated balance sheet in the following accounts:
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Inventories
  $ 3,092     $ 1,112  
Accrued expenses
    10       818  
    $ 3,102     $ 1,930  

 
Intangible Assets: The following tables present the details of the Company’s total acquisition-related intangible assets:
 
   
Weighted Average
   
July 3, 2009
   
October 3, 2008
 
   
Useful Life 
(in years)
   
Cost
   
Accumulated Amortization
   
Net
   
Cost
   
Accumulated Amortization
   
Net
 
VED Core Technology
    50     $ 30,700     $ (3,347 )   $ 27,353     $ 30,700     $ (2,887 )   $ 27,813  
VED Application Technology
    25       19,800       (4,307 )     15,493       19,800       (3,713 )     16,087  
X-ray Generator and Satcom Application Technology
    15       8,000       (2,908 )     5,092       8,000       (2,508 )     5,492  
Antenna and Telemetry Technology
    25       5,300       (400 )     4,900       5,300       (241 )     5,059  
Customer backlog
    1       580       (580 )     -       580       (580 )     -  
Land lease
    46       11,810       (1,371 )     10,439       11,810       (1,181 )     10,629  
Tradename
   
20 - Indefinite
      7,600       (220 )     7,380       7,600       (55 )     7,545  
Customer list and programs
    25       6,280       (1,150 )     5,130       6,280       (950 )     5,330  
Noncompete agreement
    5       640       (305 )     335       640       (208 )     432  
Patent application fees
    -       129       -       129       147       -       147  
            $ 90,839     $ (14,588 )   $ 76,251     $ 90,857     $ (12,323 )   $ 78,534  
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
    Intangible assets, net as of July 3, 2009 include a total of approximately $0.1 million of application costs and associated legal costs incurred to obtain certain patents. Once obtained, these patents will be amortized on a straight-line basis and charged to operations over their estimated useful lives, not to exceed 17 years.
 
The amortization of intangible assets amounted to $0.8 million and $2.3 million for the three and nine months ended July 3, 2009, respectively, and $0.8 million and $2.5 million for the corresponding periods of fiscal year 2008.
 
The estimated future amortization expense of intangible assets, excluding the Company’s unamortized tradenames, is as follows:
 
Fiscal Year
 
Amount
 
2009 (remaining three months)
  $ 757  
2010
    3,005  
2011
    3,005  
2012
    2,990  
2013
    2,899  
Thereafter
    60,395  
    $ 73,051  

Goodwill:    The following table sets forth the changes in goodwill by reportable segment:
 
   
Reportable Segments
 
   
VED
   
Satcom
   
Other
   
Total
 
Balance at October 3, 2008
  $ 132,897     $ 13,830     $ 15,884     $ 162,611  
Purchase accounting adjustment
    (272 )     (109 )     -       (381 )
Balance at July 3, 2009
  $ 132,625     $ 13,721     $ 15,884     $ 162,230  

The total purchase accounting adjustment comprised (1) $0.3 million in correction of income tax rates that were used to establish Canadian deferred tax accounts related to the Company’s merger in fiscal year 2004, and (2) $0.1million tax benefit realized from the exercise of certain fully vested stock options that were acquired in connection with such merger.
 
Product Warranty:    The following table summarizes the activity related to product warranty:
 
   
Nine Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Beginning accrued warranty
  $ 4,159     $ 5,578  
Estimates for product warranty, charged to cost of sales
    2,990       2,171  
Actual costs of warranty claims
    (3,347 )     (3,216 )
Ending accrued warranty
  $ 3,802     $ 4,533  
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
Accumulated Other Comprehensive Loss:    The following table provides the components of accumulated other comprehensive loss in the condensed consolidated balance sheets:
 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
Unrealized loss on cash flow hedges, net of tax
  $ 1,471     $ 1,587  
Unrealized actuarial loss and prior service credit
               
for pension liability, net of tax
    254       222  
    $ 1,725     $ 1,809  

4.           Financial Instruments
 
Effective October 4, 2008, the Company adopted SFAS No. 157 for financial assets and liabilities. SFAS No. 157 establishes a framework for measuring fair value and expands disclosures about fair value measurements by establishing a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under SFAS No. 157 are described below:

Level 1
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
Level 2
Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the asset or the liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
 
Level 3
Unobservable inputs reflecting the Company’s own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
 
 
Under SFAS No. 157, the fair value is the price that would be received to sell an asset or paid to transfer a liability that assumes an orderly transaction in the most advantageous market at the measurement date.
 
The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, restricted cash, available-for-sale securities and derivative instruments. As of July 3, 2009, financial assets utilizing Level 1 inputs included cash equivalents, such as money market and overnight U.S. Government securities and available-for-sale securities, such as mutual funds. Financial assets and liabilities utilizing Level 2 inputs included restricted cash in the form of certificates of deposit, foreign currency derivatives and interest rate swap derivatives. The Company does not have any financial assets or liabilities requiring the use of Level 3 inputs.

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

The following table sets forth financial instruments carried at fair value within the SFAS No. 157 hierarchy as of July 3, 2009:

   
Fair Value Measurements at Reporting Date Using
 
         
Quoted Prices in Active Markets for Identical Assets
   
Significant Other Observable Inputs
   
Significant Unobservable Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets:
                       
Money market and overnight U.S. Government securities1
  $ 30,664     $ 30,664     $ -     $ -  
Certificates of deposit2
    502       -       502       -  
Mutual funds3
    134       134       -       -  
Foreign exchange forward derivatives4
    1,423       -       1,423       -  
Total assets at fair value
  $ 32,723     $ 30,798     $ 1,925       -  
                                 
Liabilities:
                               
Interest rate swap derivative5
  $ 2,606     $ -     $ 2,606     $ -  
Foreign exchange forward derivatives4
    459       -       459       -  
Total liabilities at fair value
  $ 3,065     $ -     $ 3,065     $ -  
   
1 The money market and overnight U.S. Government securities are classified as part of cash and cash equivalents in the condensed consolidated balance sheet.
 
2 The certificates of deposit are classified as part of restricted cash in the condensed consolidated balance sheet.
 
3 The mutual funds are classified as part of other long-term assets in the condensed consolidated balance sheet.
 
4 The foreign currency derivatives are classified as part of prepaid and other current assets and accrued expenses in the condensed consolidated balance sheet.
 
5 The interest rate swap derivatives are classified as part of accrued expenses and other long-term liabilities in the condensed consolidated balance sheet.
 

 
Investments Other Than Derivatives
 
In general and where applicable, the Company uses quoted prices in active markets for identical assets or liabilities to determine fair value. This pricing methodology applies to the Company’s Level 1 investments, such as money market, U.S. Government securities and mutual funds.

If quoted prices in active markets for identical assets or liabilities are not available to determine fair value, then the Company would use quoted prices for similar assets and liabilities or inputs other than the quoted prices that are observable either directly or indirectly. These investments, such as certificates of deposit, would be included in Level 2.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Derivatives
 
The Company executes foreign exchange forward contracts to purchase Canadian dollars and holds a pay-fixed receive-variable interest rate swap contract, all executed in the retail market with its relationship banks. For recognizing the most appropriate value, the Company uses an in-exchange valuation premise which considers the assumptions that market participants would use in pricing the derivatives. The Company has elected to use the income approach and uses observable (Level 2) market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount. Level 2 inputs for derivative valuations are midmarket quoted prices for similar assets or liabilities in active markets and inputs other than quoted prices that are observable for the asset or liability.

Key inputs for currency derivatives are spot rates, forward rates, interest rates and credit derivative rates. The spot rate for the Canadian dollar is the same spot rate used for all balance sheet translations at the measurement date. Forward premiums/discounts and interest rates are interpolated from commonly quoted intervals. Once valued, each forward is identified as either an asset or liability. Assets are further discounted using counterparty annual credit default rates, and liabilities are valued using the Company’s credit as reflected in the spread paid over LIBOR on the term loan under the Company’s senior credit facilities.

Key inputs for valuing the interest rate swap are the cash rates used for the short term (under three months), futures rates for up to three years and LIBOR swap rates for periods beyond. These inputs are used to derive variable resets for the swap as well as to discount future fixed and variable cash flows to present value at the measurement date. A credit spread is used to further discount each net cash flow using, for assets, counterparty credit default rates and, for liabilities, the Company’s credit spread over LIBOR on the term loan under the Company’s senior credit facilities.

See Note 6 for further information regarding the Company’s derivative instruments.
 
Other Financial Instruments
 
The Company’s other financial instruments include cash, restricted cash, accounts receivable, accounts payable and long-term debt. Except for long-term debt, the carrying value of these financial instruments approximate fair values because of their relatively short maturity. See Note 5 for the estimated fair value of the Company’s debt.
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

5.           Long-term Debt
 
Long-term debt comprises the following:
 
   
July 3, 2009
   
October 3, 2008
 
   
Carrying Value
   
Fair Value
   
Carrying Value
   
Fair Value
 
Term loan, expiring 2014
  $ 84,000     $ 79,800     $ 88,750     $ 88,750  
8% Senior subordinated notes due 2012
    117,000       111,735       125,000       116,875  
Floating rate senior notes due 2015, carrying value net of issue discount of $81 and $90
    11,919       10,079       11,910       12,180  
      212,919       201,614       225,660       217,805  
Less:  Current portion
    -       -       1,000       1,000  
Long-term portion
  $ 212,919     $ 201,614     $ 224,660     $ 216,805  
                                 
Standby letters of credit
  $ 5,563             $ 4,609          

The fair values of the Company's long-term debt were estimated using quoted market prices where available. For long-term debt not actively traded, fair values were estimated using discounted cash flow analyses, based on the Company's current estimated incremental borrowing rates for similar types of borrowing arrangements.
 
Senior Credit Facilities: On August 1, 2007, CPI amended and restated its then existing senior credit facilities. The amended and restated senior credit facilities (“Senior Credit Facilities”) provide for borrowings of up to an aggregate principal amount of $160 million, consisting of a $100 million term loan facility (“Term Loan”) and a $60 million revolving credit facility (“Revolver”), with a sub-facility of $15 million for letters of credit and $5 million for swing line loans. Upon certain specified conditions, including maintaining a senior secured leverage ratio of 3.75:1 or less on a pro forma basis, CPI may seek commitments for a new class of term loans, not to exceed $125 million in the aggregate. The Senior Credit Facilities are guaranteed by CPI International and all of CPI’s domestic subsidiaries and are secured by substantially all of the assets of CPI International, CPI and CPI’s domestic subsidiaries.
 
Except as provided in the following sentence, the Term Loan will mature on August 1, 2014 and the Revolver will mature on August 1, 2013. However, if, prior to August 1, 2011, CPI has not repaid or refinanced its 8% Senior Subordinated Notes due 2012, both the Term Loan and the Revolver will mature on August 1, 2011.
 
The Senior Credit Facilities replaced CPI’s previous senior credit facilities of $130 million. On the closing date of the Senior Credit Facilities, CPI borrowed $100 million under the Term Loan. Borrowings under the Senior Credit Facilities bear interest at a rate equal to, at CPI’s option, LIBOR or the ABR plus the applicable margin. The ABR is the greater of the (a) the prime rate and (b) the federal funds rate plus 0.50%. For Term Loans, the applicable margin will be 2.00% for LIBOR borrowings and 1.00% for ABR borrowings. The applicable margins under the Revolver vary depending on CPI’s leverage ratio, as defined in the Senior Credit Facilities, and range from 1.25% to 2.00% for LIBOR borrowings and from 0.25% to 1.00% for ABR borrowings.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

In addition to customary fronting and administrative fees under the Senior Credit Facilities, CPI will pay letter of credit participation fees equal to the applicable LIBOR margin per annum on the average daily amount of the letter of credit exposure and a commitment fee on the average daily unused commitments under the Revolver. The commitment fee will vary depending on CPI’s leverage ratio, as defined in the Senior Credit Facilities and will range from 0.25% to 0.50%.
 
The Senior Credit Facilities require that CPI repay $250,000 of the Term Loan at the end of each fiscal quarter prior to the maturity date of the Term Loan, with the remainder due on the maturity date. CPI is required to prepay its outstanding loans under the Senior Credit Facilities, subject to certain exceptions and limitations, with net cash proceeds received from certain events, including, without limitation, (1) all such proceeds received from certain asset sales by CPI International, CPI or any of CPI’s subsidiaries, (2) all such proceeds received from issuances of debt (other than certain specified permitted debt) or preferred stock by CPI International, CPI or any of CPI’s subsidiaries, and (3) all such proceeds paid to CPI International, CPI or any of CPI’s subsidiaries from casualty and condemnation events in excess of amounts applied to replace, restore or reinvest in any properties for which proceeds were paid within a specified period.
 
If CPI’s leverage ratio, as defined in the Senior Credit Facilities, exceeds 3.5:1 at the end of any fiscal year, CPI will also be required to make an annual prepayment within 90 days after the end of such fiscal year equal to 50% of excess cash flow, as defined in the Senior Credit Facilities, less optional prepayments made during the fiscal year. CPI can make optional prepayments on the outstanding loans at any time without premium or penalty, except for customary “breakage” costs with respect to LIBOR loans.
 
The Senior Credit Facilities contain a number of covenants that, among other things, restrict, subject to certain exceptions, the ability of CPI International, CPI or any of CPI’s subsidiaries to: sell assets; engage in mergers and acquisitions; pay dividends and distributions or repurchase their capital stock; incur additional indebtedness or issue equity interests; make investments and loans; create liens or further negative pledges on assets; engage in certain transactions with affiliates; enter into sale and leaseback transactions; amend agreements or make prepayments relating to subordinated indebtedness; and amend or waive provisions of charter documents in a manner materially adverse to the lenders. CPI and its subsidiaries must comply with a maximum capital expenditure limitation and a maximum total secured leverage ratio, each calculated on a consolidated basis for CPI.
 
CPI made repayments on the Term Loan of $4.75 million during the first quarter of fiscal year 2009, $11.0 million during fiscal year 2008 and $250,000 during fiscal year 2007, leaving a principal balance of $84.0 million as of July 3, 2009.
 
At July 3, 2009, the amount available for borrowing under the Revolver, after taking into account the Company‘s outstanding letters of credit of $5.6 million, was approximately $54.4 million.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

8% Senior Subordinated Notes due 2012 of CPI:  As of July 3, 2009, CPI had $117.0 million in aggregate principal amount of its 8% Senior Subordinated Notes due 2012 (the “8% Notes”) after giving effect to the repurchase of a total of $8.0 million during the first three quarters of fiscal year 2009. The Company repurchased $3.0 million aggregate principal amount of the 8% Notes in January 2009 at a discount of 8.5% to par value. The Company paid approximately $2.9 million, including accrued interest of $0.1 million, for the repurchase and realized a net gain of approximately $0.2 million. The Company also repurchased $5.0 million aggregate principal amount of the 8% Notes in June 2009 at a discount of 2.75% to par value. The Company paid approximately $5.0 million, including accrued interest of $0.2 million, for the repurchase and realized a net gain of approximately $0.1 million. The 8% Notes have no sinking fund requirements.

The 8% Notes bear interest at the rate of 8.0% per year, payable on February 1 and August 1 of each year. The 8% Notes will mature on February 1, 2012. The 8% Notes are unsecured obligations, jointly and severally guaranteed by CPI International and each of CPI’s domestic subsidiaries. The payment of all obligations relating to the 8% Notes are subordinated in right of payment to the prior payment in full in cash or cash equivalents of all senior debt (as defined in the indenture governing the 8% Notes) of CPI, including debt under the Senior Credit Facilities. Each guarantee of the 8% Notes is and will be subordinated to guarantor senior debt (as defined in the indenture governing the 8% Notes) on the same basis as the 8% Notes are subordinated to CPI’s senior debt.
 
At any time or from time to time, CPI, at its option, may redeem the 8% Notes, in whole or in part, at the redemption prices (expressed as percentages of principal amount) set forth below, together with accrued and unpaid interest thereon, if any, to the redemption date, if redeemed during the 12-month period beginning on February 1 of the years indicated below:
 
Year
 
Optional Redemption Price
 
2009
    102 %
2010 and thereafter
    100 %

Upon a change of control, CPI may be required to purchase all or any part of the 8% Notes for a cash price equal to 101% of the principal amount, plus accrued and unpaid interest thereon, if any, to the date of purchase.

The indenture governing the 8% Notes contains a number of covenants that, among other things, restrict, subject to certain exceptions, the ability of CPI and its restricted subsidiaries (as defined in the indenture governing the 8% Notes) to incur additional indebtedness, sell assets, consolidate or merge with or into other companies, pay dividends or repurchase or redeem capital stock or subordinated indebtedness, make certain investments, issue capital stock of their subsidiaries, incur liens and enter into certain types of transactions with their affiliates.
 
Events of default under the indenture governing the 8% Notes include: failure to make payments on the 8% Notes when due; failure to comply with covenants in the indenture governing the 8% Notes; a default under certain other indebtedness of CPI or any of its restricted subsidiaries that is caused by a failure to make payments on such indebtedness or that results in the acceleration of the maturity of such indebtedness; the existence of certain final judgments or orders against CPI or any of the restricted subsidiaries; and the occurrence of certain insolvency or bankruptcy events.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
        Floating Rate Senior Notes due 2015 of CPI International: As of July 3, 2009, $12.0 million of aggregate principal amount remained outstanding under CPI International’s Floating Rate Senior Notes due 2015 (the “FR Notes”) after giving effect to the redemption of $10.0 million aggregate principal amount and $58.0 million aggregate principal amount in fiscal years 2008 and 2007, respectively. The FR Notes were originally issued at a 1% discount and have no sinking fund requirements.
 
The FR Notes require interest payments at an annual interest rate, reset at the beginning of each semi-annual period, equal to the then six-month LIBOR plus 5.75%, payable semiannually on February 1 and August 1 of each year. The interest rate on the semi-annual interest payment due August 1, 2009 is 7.38% per annum. CPI International may, at its option, elect to pay interest through the issuance of additional FR Notes for any interest payment date on or before February 1, 2010. If CPI International elects to pay interest through the issuance of additional FR Notes, the annual interest rate on the FR Notes will increase by an additional 1% step-up, with the step-up increasing by an additional 1% for each interest payment made through the issuance of additional FR Notes (up to a maximum of 4%). The FR Notes will mature on February 1, 2015.
 
The FR Notes are general unsecured obligations of CPI International. The FR Notes are not guaranteed by any of CPI International’s subsidiaries but are structurally subordinated to all existing and future indebtedness and other liabilities of CPI International’s subsidiaries. The FR Notes are senior in right of payment to CPI International’s existing and future indebtedness that is expressly subordinated to the FR Notes.
 
Because CPI International is a holding company with no operations of its own, CPI International relies on distributions from Communications & Power Industries to satisfy its obligations under the FR Notes. The Senior Credit Facilities and the indenture governing the 8% Notes restrict CPI’s ability to make distributions to CPI International. The Senior Credit Facilities prohibit CPI from making distributions to CPI International unless there is no default under the Senior Credit Facilities and CPI satisfies a senior secured leverage ratio of 3.75:1 and, in the case of distributions to pay amounts other than interest on the FR Notes, the amount of the distribution and all prior such distributions do not exceed a specified amount. The indenture governing the 8% Notes prohibits CPI from making distributions to CPI International unless, among other things, there is no default under the indenture and the amount of the proposed dividend plus all previous Restricted Payments (as defined in the indenture governing the 8% Notes) does not exceed a specified amount.
 
At any time or from time to time, CPI International, at its option, may redeem the FR Notes in whole or in part at the redemption prices (expressed as percentages of principal amount) set forth below, together with accrued and unpaid interest thereon, if any, to the redemption date, if redeemed during the 12-month period beginning on February 1 of the years indicated below:
 
Year
 
Optional Redemption Price
 
2009
    101 %
2010 and thereafter
    100 %


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Upon a change of control, as defined in the indenture governing the FR Notes, CPI International may be required to purchase all or any part of the outstanding FR Notes for a cash price equal to 101% of the principal amount, plus accrued and unpaid interest thereon, if any, to the date of purchase.
 
The indenture governing the FR Notes contains certain covenants that, among other things, limit the ability of CPI International and its restricted subsidiaries (as defined in the indenture governing the FR Notes) to incur additional indebtedness, sell assets, consolidate or merge with or into other companies, pay dividends or repurchase or redeem capital stock or subordinated indebtedness, make certain investments, issue capital stock of their subsidiaries, incur liens and enter into certain types of transactions with their affiliates.
 
Events of default under the indenture governing the FR Notes include: failure to make payments on the FR Notes when due; failure to comply with covenants in the indenture governing the FR Notes; a default under certain other indebtedness of CPI International or any of its restricted subsidiaries that is caused by a failure to make payments on such indebtedness or that results in the acceleration of the maturity of such indebtedness; the existence of certain final judgments or orders against CPI International or any of the restricted subsidiaries; and the occurrence of certain insolvency or bankruptcy events.
 
Debt Maturities:    As of July 3, 2009, maturities on long-term debt were as follows:
 
Fiscal Year
 
Term
Loan
   
8% Senior
Subordinated Notes
   
Floating Rate
Senior Notes
   
Total
 
2009 (remaining three months)
  $ -     $ -     $ -     $ -  
2010
    -       -       -       -  
2011
    84,000       -       -       84,000  
2012
    -       117,000       -       117,000  
2013
    -       -       -       -  
Thereafter
    -       -       12,000       12,000  
    $ 84,000     $ 117,000     $ 12,000     $ 213,000  

The above table assumes (1) that the respective debt instruments will be outstanding until their scheduled maturity dates, except for the Term Loan under the Senior Credit Facilities, which is assumed to mature on the earlier date of August 1, 2011 as described above under “Senior Credit Facilities,” and (2) a debt level based on mandatory repayments according to the contractual amortization schedule. The above table also excludes any optional prepayments.
 
As of July 3, 2009, the Company was in compliance with the covenants under the indentures governing the 8% Notes and FR Notes and the agreements governing the Senior Credit Facilities, and the Company expects to remain in compliance with those covenants throughout the remainder of fiscal year 2009.
 
Interest rate swap agreements: See Note 6 for information on the interest rate swap agreements entered into by the Company to hedge the interest rate exposure associated with the Term Loan.

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

6.           Derivative Instruments and Hedging Activities
 
In March 2008, the FASB issued SFAS No. 161, which amends and expands the disclosure requirements of SFAS No. 133 to provide an enhanced understanding of the use of derivative instruments, how they are accounted for under SFAS 133 and their effect on financial position, financial performance and cash flows. The Company adopted the disclosure provisions of SFAS No. 161 in the second quarter of fiscal year 2009.

Foreign Exchange Forward Contracts: Although the majority of the Company’s revenue and expense activities are transacted in U.S. dollars, the Company does transact business in foreign countries. The Company’s primary foreign currency cash flows are in Canada and several European countries. In an effort to reduce its foreign currency exposure to Canadian dollar denominated expenses, the Company enters into Canadian dollar forward contracts to hedge the Canadian dollar denominated costs for its manufacturing operation in Canada. The Company does not engage in currency speculation.

The Company’s Canadian dollar forward contracts in effect as of July 3, 2009 have durations of 12 to 17 months. These contracts are designated as a cash flow hedge and are considered highly effective, as defined by SFAS No. 133. Unrealized gains and losses from foreign exchange forward contracts are included in accumulated other comprehensive income (loss) in the consolidated balance sheets, and the Company anticipates recognizing the entire unrealized gain or loss in operating earnings within the next five fiscal quarters. Changes in the fair value of foreign currency forward contracts due to changes in time value are excluded from the assessment of effectiveness and are immediately recognized in general and administrative expenses in the condensed consolidated statements of income and comprehensive income. The time value was not material for the first three quarters of fiscal years 2009 and 2008. If the transaction being hedged fails to occur, or if a portion of any derivative is ineffective, then the Company immediately recognizes the gain or loss on the associated financial instrument in general and administrative expenses in the condensed consolidated statements of income and comprehensive income. No ineffective amounts were recognized due to anticipated transactions failing to occur in the first three quarters of fiscal years 2009 and 2008.

As of July 3, 2009, the Company had entered into Canadian dollar forward contracts for approximately $37.7 million (Canadian dollars), or approximately 83% of estimated Canadian dollar denominated expenses for July 2009 through June 2010, at an average rate of approximately 0.84 U.S. dollar to Canadian dollar.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Interest Rate Contracts: The Company also uses derivative instruments in order to manage interest costs and risk associated with its long-term debt. During fiscal year 2007, the Company entered into an interest rate swap contract (the “2007 Swap”) to receive three-month USD-LIBOR-BBA (British Bankers’ Association) interest and pay 4.77% fixed rate interest. Net interest positions are settled quarterly. The Company has structured the 2007 Swap with decreasing notional amounts such that it is less than the balance of its Term Loan under the Senior Credit Facilities discussed in Note 5. The notional value of the 2007 Swap was $55.0 million at July 3, 2009 and represented approximately 65% of the aggregate Term Loan balance. The Swap agreement is effective through June 30, 2011. Under the provisions of SFAS No. 133, this arrangement was initially designated and qualified as an effective cash flow hedge of interest rate risk related to the Term Loan, which permitted recording the fair value of the 2007 Swap and corresponding unrealized gain or loss to accumulated other comprehensive income (loss) in the consolidated balance sheets. The interest rate swap gain or loss is included in the assessment of hedge effectiveness. Gains and losses representing hedge ineffectiveness are immediately recognized in interest expense, net in the condensed consolidated statements of income and comprehensive income.

See Note 4, Financial Instruments, for further information regarding the Company’s derivative instruments.

The following table summarizes the fair value of derivative instruments designated as cash flow hedges at July 3, 2009:
 
 
Asset Derivatives
 
Liability Derivatives
 
 
Balance Sheet
Location
 
Fair Value
 
Balance Sheet
Location
 
Fair Value
 
Derivatives designated as hedging instruments under SFAS No. 133
             
                 
     Interest rate contracts
Prepaid and other current assets
  $ -  
Accrued expenses
  $ (1,859 )
     Interest rate contracts
Other long-term assets
    -  
Other long-term liabilities
    (747 )
                     
     Forward contracts
Prepaid and other current assets
    1,423  
Accrued expenses
    (459 )
     Forward contracts
Other long-term assets
    -  
Other long-term liabilities
    -  
                     
Total derivatives designated as hedging instruments under SFAS No. 133   $ 1,423       $ (3,065 )

As of July 3, 2009, all of the Company’s derivative instruments were classified as hedging instruments under SFAS No. 133.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

The following table summarizes the effect of derivative instruments on the condensed consolidated statement of income and comprehensive income for the nine months ended July 3, 2009:
 
Derivatives in Statement 133 Cash Flow Hedging Relationships
 
Amount of
Gain (Loss) Recognized
in OCI on Derivative
(Effective Portion)
 
Location of
Gain (Loss) Reclassified from Accumulated
OCI into Income
(Effective Portion)
 
Amount of
Gain (Loss) Reclassified from Accumulated OCI into Income
(Effective Portion)
 
Location of
Gain (Loss) Recognized in Income on Derivative (Ineffective and Excluded Portion)
 
Amount of Gain (Loss) Recognized in Income on Derivative (Ineffective and Excluded Portion )
 Interest rate contracts
  $ (1,889 )
 Interest expense, net
  $ (1,228 )
 Interest expense, net
  $ (40 )  
                               
 Forward contracts
    (2,791 )
 Cost of sales
    (3,167 )
 General and administrative
    (285 )
(a)
 Forward contracts
       
 Research and development
    (176 )            
 Forward contracts
       
 Selling and marketing
    (96 )            
 Forward contracts
       
 General and administrative
    (289 )            
 Total
  $ (4,680 )     $ (4,956 )     $ (325 )  
   
(a) The amount of loss recognized in income represents a $286 loss related to the amount excluded from the assessment of hedge effectiveness, net of a $1 gain related to the ineffective portion of the hedging relationships.
 
 
As a result of the use of derivative instruments, the Company is exposed to the risk that counterparties to derivative contracts will fail to meet their contractual obligations. The Company does not hold collateral or other security from its counterparties supporting its derivative instruments. To mitigate the counterparty credit risk, the Company has a policy of only entering into contracts with carefully selected major financial institutions based upon their credit ratings and other factors. The Company regularly reviews its credit exposure balances as well as the creditworthiness of its counterparties.

In addition, the Company’s interest rate swap contract is subject to an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”). The ISDA Master Agreement allows for the aggregation of the market exposures and termination of all transactions between the Company and its counterparties in the event a default (as defined in the ISDA Master Agreement) occurs in respect of either party.
 
When the Company’s derivatives are in a net asset position, such as the case with the Company’s forward foreign exchange contract derivatives at July 3, 2009, the Company is exposed to credit loss from nonperformance by the counterparty. If the counterparty fails to perform, credit risk with such counterparty is equal to the extent of the fair value gain in the derivative. At July 3, 2009, the Company’s interest rate contract derivatives were in a net liability position, and the Company, therefore, was not exposed to the interest rate contract counterparty credit risk.
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

7.           Commitments and Contingencies
 
Leases: The Company is committed to minimum rentals under non-cancelable operating lease agreements, primarily for land and facility space, that expire on various dates through 2050. Certain of the leases provide for escalating lease payments. Future minimum lease payments for all non-cancelable operating lease agreements at July 3, 2009 were as follows:
 
Fiscal Year
Operating Leases
 
2009 (remaining three months)
  $ 578  
2010
    1,748  
2011
    708  
2012
    510  
2013
    433  
Thereafter
    2,897  
Total future minimum lease payments
  $ 6,874  
 
Real estate taxes, insurance and maintenance are also obligations of the Company. Rental expense under non-cancelable operating leases amounted to $0.6 million and $2.0 million for the three and nine months ended July 3, 2009, respectively, and to $0.5 million and $1.7 million for the corresponding periods of fiscal year 2008. Assets subject to capital leases at July 3, 2009 and October 3, 2008 were not material.

Restricted cash: The Company has restricted cash of $0.8 million as of July 3, 2009 and October 3, 2008 consisting primarily of bank guarantees from customer advance payments to the Company’s international subsidiaries. The bank guarantees become unrestricted cash when performance under the sales contract is complete. 

Purchase commitments: As of July 3, 2009, the Company had the following known purchase commitments, which include primarily future purchases for inventory-related items under various purchase arrangements as well as other obligations in the ordinary course of business that the Company cannot cancel or where it would be required to pay a termination fee in the event of cancellation:

Fiscal Year
 
Purchase Contracts
 
2009 (remaining three months)
  $ 18,098  
2010
    11,046  
2011
    1,662  
2012
    229  
2013
    -  
Total purchase commitments
  $ 31,035  


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Contingent Earnout Consideration: Under the terms of the purchase agreement for the acquisition of Malibu Research, Inc. (“Malibu”) in August 2007, in addition to the $20.5 million of net cash consideration paid for the acquisition, the Company may be required to pay a potential earnout to the former stockholders of Malibu of up to $14.0 million, which is primarily contingent upon the achievement of certain financial objectives over the three years following the acquisition (“Financial Earnout”) and a discretionary earnout of up to $1.0 million contingent upon achievement of certain succession planning goals by June 30, 2010. As of July 3, 2009, the Company has not accrued any of these contingent earnout amounts as achievement of the objectives and goals has not occurred. Any earnout consideration paid based on financial performance will be recorded as additional goodwill. Any discretionary succession earnout consideration paid will be recorded as general and administrative expense. No earnout was earned for the first and second earnout periods, and the maximum potential Financial Earnout that could be earned over the three years following the acquisition has been reduced from $14.0 million to $7.7 million based on the performance in the first and second earnout periods. Based on its current financial forecasts for Malibu, the Company expects that no earnout will ultimately be payable for the third earnout period.

Indemnification: As permitted under Delaware law, the Company has agreements whereby the Company indemnifies its officers, directors and certain employees for certain events or occurrences while the employee, officer or director is, or was serving, at the Company’s request in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has Director and Officer insurance policies that limit its exposure and may enable it to recover a portion of any future amounts paid.

The Company has entered into other standard indemnification agreements in its ordinary course of business. Pursuant to these agreements, the Company agrees to indemnify, defend, hold harmless and to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally the Company’s business partners or customers, in connection with any patent, copyright or other intellectual property infringement claim by any third-party with respect to the Company’s products. The term of these indemnification agreements is generally perpetual after execution of the agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. Management believes that the likelihood of loss under these agreements is remote.

Employment Agreements: The Company has entered into employment agreements with certain members of the executive management, which include provisions for the continued payment of salary, benefits and a pro-rata portion of an annual bonus for periods ranging from 12 months to 30 months upon certain terminations of employment.
 
Contingencies: From time to time, the Company may be subject to claims that arise in the ordinary course of business. Except as noted below, in the opinion of management, all such matters involve amounts that would not have a material adverse effect on the Company's consolidated financial position if unfavorably resolved.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

During the first quarter of fiscal year 2009, the Company received a notice from a customer purporting to terminate a sales contract due to alleged nonperformance. The Company plans to contest this matter vigorously. The Company recorded certain costs in the fourth quarter of fiscal year 2008 as a result of the termination; however, at this time, the Company cannot estimate the range of any further possible loss or gain with respect to this matter or whether an unfavorable resolution of this matter would have a material adverse effect on the Company's results of operations and cash flows.
 
 
8.
Stock-based Compensation Plans
 
As of July 3, 2009, the Company had an aggregate of 1.7 million shares of its common stock available for future grant and approximately 3.4 million options outstanding under its various equity plans. Awards are subject to terms and conditions as determined by the Company’s board of directors.

Stock Options: The following table summarizes stock option activity as of July 3, 2009 and changes during the nine months ended July 3, 2009 under the Company’s stock option plans:

   
Outstanding Options
   
Exercisable Options
 
   
Number of
Shares
   
Weighted-Average Exercise Price
   
Weighted-Average Remaining Contractual Term (Years)
   
Aggregate Intrinsic Value
   
Number of Shares
   
Weighted-Average Exercise Price
   
Weighted-Average Remaining Contractual Term (Years)
   
Aggregate Intrinsic Value
 
Balance at October 3, 2008
    3,349,294     $ 6.23       5.77     $ 24,363       2,556,762     $ 3.83       5.16     $ 23,052  
Granted
    108,000       10.00                                                  
Exercised
    (55,204 )     1.49                                                  
Forfeited or cancelled
    (7,399 )     16.38                                                  
Balance at July 3, 2009
    3,394,691     $ 6.41       5.21     $ 15,377       2,848,424     $ 4.73       4.68     $ 15,377  
 
During the first quarter of fiscal year 2009, the Company granted its officers 108,000 shares of stock options that are subject to time vesting and market performance vesting conditions. All of such shares are broken up into two tranches (each a "Tranche"), each consisting of one-half of the nonvested shares. The nonvested shares in each Tranche become fully vested only if both the time vesting conditions and the performance conditions are satisfied with respect to such nonvested shares. The time vesting conditions with respect to 25% of the nonvested shares in each Tranche generally will be satisfied on each of the first four anniversaries of the grant date. The market performance conditions of each Tranche are based on specified price thresholds reached by the Company's common stock. The nonvested shares in Tranche One are subject to a $13.50 stock price threshold, and the nonvested shares in Tranche Two are subject to a $16.00 stock price threshold. In order for the market performance conditions to be satisfied with respect to a Tranche, the average closing share price of the Company's common stock must be at or above the applicable stock price threshold amount for 20 consecutive trading days. The stock options have a term of 10 years at the grant date.

The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing stock price of $9.31 as of July 3, 2009, which would have been received by the option holders had all option holders exercised their options and sold the shares received upon such exercises as of that date. As of July 3, 2009, approximately 2.5 million exercisable options were in-the-money.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

During the three and nine months ended July 3, 2009, cash received from option exercises was $46,448 and $82,451, respectively, and the total intrinsic value of options exercised was approximately $0.4 million. During the three and nine months ended June 27, 2008, cash received from exercises was approximately $2,600, and the total intrinsic value of options exercised was $5,500. As of July 3, 2009, there was approximately $3.3 million of total unrecognized compensation costs related to nonvested stock options, which is expected to be recognized over a weighted-average vesting period of 1.5 years.

Stock Purchase Plan:  Employees purchased 22,180 shares for $0.2 million and 93,031 shares for $0.8 million in the three and nine months ended July 3, 2009, respectively, under the 2006 Employee Stock Purchase Plan (the “2006 ESPP”). As of July 3, 2009, there were no unrecognized compensation costs related to rights to acquire stock under the 2006 ESPP.

Restricted Stock and Restricted Stock Units: There were 223,498 and 117,154 shares outstanding of nonvested restricted stock and restricted stock units granted to directors and employees as of July 3, 2009 and October 3, 2008, respectively. The restricted stock and restricted stock units generally vest over periods of one to four years. Upon vesting, each restricted stock unit will automatically convert into one share of common stock of CPI International.

A summary of the status of the Company’s nonvested restricted stock and restricted stock unit awards as of July 3, 2009 and of changes during the nine months then ended is presented below:
 
   
Number of Shares
   
Weighted-Average Grant-Date Fair Value Per Share
 
Nonvested at October 3, 2008
    117,154     $ 15.28  
Granted
    142,721       8.87  
Vested
    (36,377 )     14.81  
Forfeited
    -       -  
Nonvested at July 3, 2009
    223,498     $ 11.26  
 
During the first quarter of fiscal year 2009, the Company granted its officers and certain other employees, respectively, 36,000 and 102,900 shares of restricted stock or restricted stock units. The restricted stock and restricted stock units granted to the Company’s officers are subject to time vesting and market performance vesting conditions similar to those applicable to the stock option grants described above, except the time vesting conditions with respect to 25% of the nonvested shares will be satisfied on the third trading day following the Company's issuance of its press release reporting first quarter financial results in each of 2010, 2011, 2012 and 2013, but no later than the end of February in each year. The restricted stock and restricted stock units granted to certain other employees of the Company are only subject to time vesting similar to that applicable to restricted stock and restricted stock units granted to the Company’s officers.

During the second quarter of fiscal year 2009, the Company granted a member of its board of directors 3,821 shares of restricted stock which will vest after one year.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Aggregate intrinsic value of the nonvested restricted stock and restricted stock unit awards at July 3, 2009 was $2.1 million. As of July 3, 2009, there was $2.1 million of unrecognized compensation costs related to restricted stock and restricted stock unit awards. The unrecognized compensation cost is expected to be recognized over a weighted average period of 1.9 years.

The Company settles stock option exercises, restricted stock awards and restricted stock units with newly issued common shares.
 
Valuation and Expense Information
 
The fair value of the Company’s time-based option awards is estimated on the date of grant using the Black-Scholes model. The fair value of each market performance-based (or combination of market performance- and time-based) option, restricted stock and restricted stock unit award is estimated on the date of grant using the Monte Carlo simulation technique in a risk-neutral framework.

The Black-Scholes and the Monte Carlo simulation valuation models were developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable and require the input of subjective assumptions, including the expected stock price volatility and estimated option life. The Company currently does not intend to pay dividends and, accordingly, no dividends have been assumed in its Black-Scholes calculation and Monte Carlo simulation. Since the Company’s common stock has not been publicly traded for a sufficient time period, the expected volatility used in prior periods was based on expected volatilities of similar companies that have a longer history of being publicly traded. Beginning with fiscal year 2009, the expected volatility is based on a blend of expected volatilities of similar companies and that of the Company based on its available historical data. The risk-free rates are based on the U.S. Treasury yield in effect at the time of the grant. Since the Company’s historical data is limited, the expected term of time-based options granted is based on the simplified method for plain vanilla options in accordance with SEC Staff Accounting Bulletin (“SAB”) No. 107. In December 2007, the SEC issued SAB No. 110, an amendment of SAB No. 107. SAB No. 110 states that the SEC Staff will continue to accept, under certain circumstances, the continued use of the simplified method beyond December 31, 2007. Accordingly, the Company will continue to use the simplified method until it has enough historical experience to provide a reasonable estimate of expected term.

There were no time-based options granted during the three and nine months ended July 3, 2009, nor during the three months ended June 27, 2008.
 
Assumptions used in the Black-Scholes model to estimate the fair value of time-based option grants during the nine months ended June 27, 2008 (specifically, in the first quarter of fiscal year 2008) are presented below.

Expected term (in years)
    6.25  
Expected volatility
    41.20 %
Risk-free rate
    3.82 %
Dividend yield
    0 %

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Assumptions used in the Monte Carlo simulation model to estimate the fair value of time- and market performance-based options first granted during the nine months ended July 3, 2009 (specifically, in the first quarter of fiscal year 2009) are presented below.

Contractual term (in years)
    10.00  
Expected volatility
    51.50 %
Risk-free rate
    3.53 %
Dividend yield
    0 %

There were no time- and market performance-based options granted during the three months ended July 3, 2009 or the three and nine months ended June 27, 2008.

The weighted-average grant-date fair value of all the options granted during the nine months ended July 3, 2009 and June 27, 2008 was $5.61 and $7.83 per share, respectively.
 
Based on the 15% discount received by the employees, the weighted-average fair value of shares issued under the 2006 ESPP was $1.40 and $1.48 per share during the three and nine months ended July 3, 2009, respectively, and $1.50 and $2.14 per share during the three and nine months ended June 27, 2008, respectively.

Assumptions used in the Monte Carlo simulation model to estimate the fair value of time- and market performance-based restricted stock and restricted stock units first granted during the nine months ended July 3, 2009 (specifically, in the first quarter of fiscal year 2009) are presented below.

Expected volatility
    51.50 %
Risk-free rate
    3.54 %
Dividend yield
    0 %
 
There were no time- and market performance-based restricted stock and restricted stock units granted during the three months ended July 3, 2009 or the three and nine months ended June 27, 2008.
 
Using the market price of the Company’s common stock on the date of grant, the weighted-average estimated fair value of restricted stock and restricted stock units granted was $8.87 and $15.22 per share during the nine months ended July 3, 2009 and June 27, 2008, respectively. There were no restricted stock or restricted stock units granted during the three months ended July 3, 2009 and June 27, 2008.

As stock-based compensation expense recognized in the condensed consolidated statements of income and comprehensive income for the three and nine months ended July 3, 2009 and for the corresponding periods of fiscal year 2008 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. SFAS No. 123(R), "Share-Based Payment," requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

The following table summarizes stock-based compensation expense for the three and nine months ended July 3, 2009 and June 27, 2008, which was allocated as follows:

   
Three Months Ended
   
Nine Months Ended
 
   
July 3,
2009
   
June 27,
2008
   
July 3,
2009
   
June 27,
2008
 
Share-based compensation cost recognized in the income statement by caption:
                   
Cost of sales
  $ 131     $ 116     $ 375     $ 307  
Research and development
    43       43       130       112  
Selling and marketing
    75       61       216       165  
General and administrative
    453       374       1,303       984  
    $ 702     $ 594     $ 2,024     $ 1,568  
                                 
Share-based compensation cost capitalized in inventory
  $ 131     $ 120     $ 386     $ 335  
Share-based compensation cost remaining in inventory at end of period
  $ 87     $ 74     $ 87     $ 74  
                                 
Share-based compensation expense by type of award:
                               
Stock options
  $ 455     $ 421     $ 1,327     $ 1,153  
Stock purchase plan
    32       39       98       114  
Restricted stock and units
    215       134       599       301  
    $ 702     $ 594     $ 2,024     $ 1,568  
 
 
The tax benefit realized from option exercises and restricted stock vesting totaled approximately $0.2 million during the three and nine months ended July 3, 2009. The tax benefit realized from option exercises and restricted stock vesting totaled approximately $3,000 and $22,000 during the three and nine months ended June 27, 2008, respectively.
 
 
9.           Income Taxes
 
The income tax benefit of $2.2 million for the nine months ended July 3, 2009 and income tax expense of $6.9 million for the nine months ended June 27, 2008 reflect estimated federal, foreign and state taxes. The effective tax rate for the nine months ended July 3, 2009 was a negative 17% and diverged from the federal and state statutory rate primarily due to several significant discrete tax benefits: (1) $5.1 million relating to adjustments to the FASB Interpretation (“FIN”) No. 48 position for the outstanding audit by the Canada Revenue Agency (“CRA”), (2) $0.7 million related to certain provisions of the California Budget Act of 2008 signed on February 20, 2009, which will allow a taxpayer to elect an alternative method to attribute taxable income to California for tax years beginning on or after January 1, 2011, which resulted in a reduction to the Company’s deferred tax liability accounts and (3) $0.9 million for adjustments to Canadian deferred tax accounts.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

The effective tax rate for the nine months ended June 27, 2008 was 32%. Income tax expense for the nine months ended June 27, 2008 includes a reduction to the Company’s annual tax rate of approximately 1% to reflect a change in estimate for Canadian tax credits and a tax benefit of approximately $0.4 million attributable to the correction of an immaterial error that arose in the fourth quarter of fiscal year 2007 relating to the warranty expense tax deduction in a foreign tax jurisdiction.
 
On December 15, 2008, the Treasury Department announced that the Fifth Protocol ("Protocol") to the U.S.-Canada Income Tax Treaty ("Treaty") entered into force. The new treaty mandates arbitration for the resolution of double taxation disputes that are not settled through the competent authority process. As a result, the Company’s US tax position related to the issues raised in the outstanding tax audit by the CRA has become more favorable, and the Company recorded income tax benefits of $5.1 million in the first quarter of fiscal year 2009. This tax benefit was recorded through a $3.0 million reduction of Canadian tax contingency reserves, inclusive of interest and the recognition of a $2.8 million income tax receivable in the U.S., partially offset by a $0.7 million increase in related deferred tax liabilities.
 
The $0.9 million adjustment to Canadian deferred tax accounts includes a $0.6 million tax benefit to reflect the reduction to Canadian corporate income tax rates and a $0.3 million tax benefit to correct the computation of certain deferred tax accounts. The $0.6 million adjustment should have been recorded in the first quarter of fiscal year 2008 rather than in the first quarter of fiscal year 2009 and the $0.3 million adjustment should have been recorded in several prior years’ financial results. These adjustments are deemed immaterial to the Company’s results of operations and financial condition in current periods as well as prior affected periods.
 
The Company is subject to U.S. federal, state and foreign income and franchise tax in various jurisdictions. Generally, fiscal years 2005 to 2008 remain open to examination by the various taxing jurisdictions and the Company has not been audited for U.S. federal income tax matters. The Company has income tax audits in progress in Canada and in several states, local and international jurisdictions in which it operates. The years under examination by the Canadian taxing authorities are 2001 to 2002. The years under examination by other taxing authorities vary, with the earliest year being 2004.
1 million of unrecognized
The Company accounts for uncertainty in income taxes in accordance with FIN No. 48, “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109.” As a result, the Company applies a more-likely-than-not recognition threshold for all income tax uncertainties. FIN No. 48 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The total unrecognized tax benefit, which excludes any related interest accruals, was $3.3 million as of July 3, 2009. Of the total unrecognized tax benefit balance, $2.1 million of unrecognized tax benefits would reduce the effective tax rate if recognized as of July 3, 2009. Estimated interest and penalties related to the underpayment of income taxes are classified as a component of tax expense in the condensed consolidated statement of income and comprehensive income and totaled to a benefit of approximately $0.9 million for the nine months ended July 3, 2009, primarily as a result of the favorable impact of the new U.S.-Canada income tax treaty on the Company’s tax contingency reserves. Accrued interest and penalties, net of interest benefits accrued on receivables anticipated as a result of the change in the U.S.-Canada treaty, were approximately $0.7 million as of July 3, 2009. The Company had minimal penalties accrued in income tax expense.
 
The Company believes that it is reasonably possible that, in the next 12 months, the amount of unrecognized tax benefits related to the resolution of federal, state and foreign matters could be reduced by $2.2 million as audits close and statutes expire.
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

10.           Earnings Per Share
 
Basic earnings per share are computed using the weighted-average number of common shares outstanding during the period excluding outstanding nonvested restricted shares subject to forfeiture. Diluted earnings per share are computed using the weighted-average number of common and dilutive potential common equivalent shares outstanding during the period. Potential common equivalent shares consist of common stock issuable upon exercise of stock options and nonvested restricted shares using the treasury stock method.
 
The following table is a reconciliation of the shares used to calculate basic and diluted earnings per share (in thousands):
 
   
Three Months Ended
   
Nine Months Ended
 
   
July 3,
2009
   
June 27,
2008
   
July 3,
2009
   
June 27,
2008
 
Weighted average common shares outstanding -- Basic
    16,362       16,395       16,316       16,384  
Effect of dilutive stock options and nonvested restricted stock awards and units
    1,215       1,274       1,112       1,335  
Weighted average common shares outstanding -- Diluted
    17,577       17,669       17,428       17,719  
 
The calculation of diluted net income per share excludes all anti-dilutive shares. For the three and nine months ended July 3, 2009, the number of anti-dilutive shares, as calculated based on the weighted average price of the Company’s common stock for the periods, was approximately 0.9 million and 1.0 million shares, respectively. For the three and nine months ended June 27, 2008, the number of anti-dilutive shares, as calculated based on the weighted average price of the Company’s common stock for the periods, was approximately 0.9 million and 0.8 million shares, respectively.
 
 
11.           Segments, Geographic and Customer Information
 
The Company’s reportable segments are VED and satcom equipment. The VED segment develops, manufactures and distributes high-power/high-frequency microwave and radio frequency signal components. The satcom equipment segment manufactures and supplies high-power amplifiers and networks for satellite communication uplink and industrial applications. Segment information reported below is consistent with the manner in which it is reviewed and evaluated by the Company’s chief operating decision maker (“CODM”), its chief executive officer, and is based on the nature of the Company’s operations and products offered to customers.

Amounts not reported as VED or satcom equipment are reported as Other. In accordance with quantitative and qualitative guidelines established by SFAS No. 131, Other includes the activities of the Company’s Malibu division and unallocated corporate expenses, such as business combination-related expenses, share-based compensation expense and certain non-recurring or unusual expenses. The Malibu division is a designer, manufacturer and integrator of advanced antenna systems for radar, radar simulators and telemetry systems, as well as for data links used in ground, airborne, unmanned aerial vehicles (“UAVs”) and shipboard systems.


 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Summarized financial information concerning the Company’s reportable segments is shown in the following tables:

   
Three Months Ended
   
Nine Months Ended
 
   
July 3,
   
June 27,
   
July 3,
   
June 27,
 
   
2009
   
2008
   
2009
   
2008
 
 Sales to external customers
                       
 VED
  $ 62,572     $ 68,770     $ 180,269     $ 206,504  
 Satcom equipment
    15,704       18,550       49,329       53,259  
 Other
    4,244       3,414       11,971       11,685  
    $ 82,520     $ 90,734     $ 241,569     $ 271,448  
 Intersegment product transfers
                               
 VED
  $ 3,536     $ 7,799     $ 13,323     $ 20,947  
 Satcom equipment
    -       9       9       72  
    $ 3,536     $ 7,808     $ 13,332     $ 21,019  
 Capital expenditures
                               
 VED
  $ 379     $ 529     $ 1,873     $ 1,873  
 Satcom equipment
    28       -       43       654  
 Other
    124       201       433       761  
    $ 531     $ 730     $ 2,349     $ 3,288  
 EBITDA
                               
 VED
  $ 15,248     $ 17,548     $ 37,449     $ 49,835  
 Satcom equipment
    1,078       1,332       3,123       3,709  
 Other
    (2,545 )     (2,814 )     (6,514 )     (9,713 )
    $ 13,781     $ 16,066     $ 34,058     $ 43,831  

   
July 3,
   
October 3,
 
   
2009
   
2008
 
Total assets
           
VED
  $ 327,806     $ 324,483  
Satcom equipment
    45,652       48,219  
Other
    94,820       94,246  
    $ 468,278     $ 466,948  
 
 
EBITDA is the measure used by the CODM to evaluate segment profit or loss. EBITDA represents earnings before net interest expense, provision for income taxes and depreciation and amortization. The Company believes that EBITDA is a more meaningful representation of segment operating performance for leveraged businesses like its own and therefore uses this metric as its internal measure of profitability. For the reasons listed below, the Company believes EBITDA provides investors better understanding of the Company’s financial performance in connection with their analysis of the Company’s business:
 
 
EBITDA is a component of the measures used by the Company’s board of directors and management team to evaluate the Company’s operating performance;
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
 
the Senior Credit Facilities contain a covenant that requires the Company to maintain a senior secured leverage ratio that contains EBITDA as a component, and the Company’s management team uses EBITDA to monitor compliance with this covenant;
 
 
EBITDA is a component of the measures used by the Company’s management team to make day-to-day operating decisions;
 
 
EBITDA facilitates comparisons between the Company’s operating results and those of competitors with different capital structures and, therefore, is a component of the measures used by the Company’s management to facilitate internal comparisons to competitors’ results and the Company’s industry in general; and
 
 
the payment of management bonuses is contingent upon, among other things, the satisfaction by the Company of certain targets that contain EBITDA as a component.
 
Other companies may define EBITDA differently and, as a result, the Company’s measure of EBITDA may not be directly comparable to EBITDA of other companies. Although the Company uses EBITDA as a financial measure to assess the performance of its business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate the Company’s business. When analyzing the Company’s performance, EBITDA should be considered in addition to, and not as a substitute for, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP.

The following table reconciles net income to EBITDA:

   
Three Months Ended
   
Nine Months Ended
 
   
July 3,
2009
   
June 27,
2008
   
July 3,
2009
   
June 27,
2008
 
Net income
  $ 3,870     $ 5,824     $ 15,214     $ 14,488  
Depreciation and amortization
    2,703       2,779       8,080       8,171  
Interest expense, net
    4,204       4,627       12,965       14,244  
Income tax expense (benefit)
    3,004       2,836       (2,201 )     6,928  
EBITDA
  $ 13,781     $ 16,066     $ 34,058     $ 43,831  
 
 
Net property, plant and equipment by geographic area were as follows:
 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
United States
  $ 45,781     $ 48,593  
Canada
    13,069       13,843  
Other
    57       51  
    $ 58,907     $ 62,487  

With the exception of goodwill, the Company does not identify or allocate assets by operating segment, nor does its CODM evaluate operating segments using discrete asset information.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

Goodwill by geographic area was as follows:
 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
United States
  $ 114,234     $ 114,297  
Canada
    47,996       48,314  
    $ 162,230     $ 162,611  
 
 
Geographic sales by customer location were as follows for external customers:
 
   
Three Months Ended
   
Nine Months Ended
 
   
July 3,
2009
   
June 27,
2008
   
July 3,
2009
   
June 27,
2008
 
United States
  $ 52,806     $ 58,131     $ 156,397     $ 174,860  
All foreign countries
    29,714       32,603       85,172       96,588  
Total sales
  $ 82,520     $ 90,734     $ 241,569     $ 271,448  

There were no individual foreign countries with sales greater than 10% of total sales for the periods presented.

The U.S. Government is the only customer that accounted for 10% or more of the Company’s consolidated sales in the three and nine months ended July 3, 2009 and in the corresponding periods of fiscal year 2008. Direct sales to the U.S. Government were $11.2 million and $37.0 million for the three and nine months ended July 3, 2009, respectively, and $18.2 million and $49.2 million for the three and nine months ended June 27, 2008, respectively. Accounts receivable from this customer represented 10% and 17% of consolidated accounts receivable as of July 3, 2009 and October 3, 2008, respectively.

 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)
 
12.           Supplemental Guarantors Condensed Consolidating Financial Information (Unaudited)
 
Issued on January 23, 2004, CPI’s 8% Notes, the current balance of which is $117.0 million, are guaranteed by CPI International and all of CPI’s domestic subsidiaries. Separate financial statements of the guarantors are not presented because (i) the guarantors are wholly owned and have fully and unconditionally guaranteed the 8% Notes on a joint and several basis and (ii) the Company’s management has determined that such separate financial statements are not material to investors. Instead, presented below are the consolidating financial statements of: (a) the parent, CPI International, (b) the issuer, CPI, (c) the guarantor subsidiaries (all of the domestic subsidiaries), (d) the non-guarantor subsidiaries, (e) the consolidating elimination entries, and (f) the consolidated totals. The accompanying consolidating financial information should be read in connection with the condensed consolidated financial statements of CPI International.
 
Investments in subsidiaries are accounted for based on the equity method. The principal elimination entries eliminate investments in subsidiaries, intercompany balances, intercompany transactions and intercompany sales.
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING BALANCE SHEET
As of July 3, 2009
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Assets
                                   
Current assets:
                                   
Cash and cash equivalents
  $ 77     $ 22,832     $ 701     $ 11,575     $ -     $ 35,185  
Restricted cash
    -       -       671       96       -       767  
Accounts receivable, net
    -       18,660       10,308       12,401       -       41,369  
Inventories
    -       43,445       7,709       18,678       (932 )     68,900  
Deferred tax assets
    -       12,325       2       589       -       12,916  
Intercompany receivable
    -       15,545       6,917       4,076       (26,538 )     -  
Prepaid and other current assets
    27       2,909       639       807       -       4,382  
Total current assets
    104       115,716       26,947       48,222       (27,470 )     163,519  
Property, plant and equipment, net
    -       42,836       2,969       13,102       -       58,907  
Deferred debt issue costs, net
    356       3,567       -       -       -       3,923  
Intangible assets, net
    -       55,343       13,693       7,215       -       76,251  
Goodwill
    -       93,312       20,973       47,945       -       162,230  
Other long-term assets
    -       3,155       293       -       -       3,448  
Intercompany notes receivable
    -       1,035       -       -       (1,035 )     -  
Investment in subsidiaries
    200,513       110,640       -       -       (311,153 )     -  
Total assets
  $ 200,973     $ 425,604     $ 64,875     $ 116,484     $ (339,658 )   $ 468,278  
                                                 
Liabilities and stockholders' equity
                                               
Current liabilities:
                                               
Accounts payable
  $ 2     $ 9,849     $ 2,248     $ 7,101     $ -     $ 19,200  
Accrued expenses
    377       17,460       1,683       2,899       -       22,419  
Product warranty
    -       1,860       512       1,430       -       3,802  
Income taxes payable
    -       2,846       84       2,632       -       5,562  
Advance payments from customers
    -       8,117       3,133       1,105       -       12,355  
Intercompany payable
    26,538       -       -       -       (26,538 )     -  
Total current liabilities
    26,917       40,132       7,660       15,167       (26,538 )     63,338  
Deferred income taxes
    -       22,561       -       4,349       -       26,910  
Intercompany notes payable
    -       -       -       1,035       (1,035 )     -  
Long-term debt, less current portion
    11,919       201,000       -       -       -       212,919  
Other long-term liabilities
    -       2,475       36       463       -       2,974  
Total liabilities
    38,836       266,168       7,696       21,014       (27,573 )     306,141  
Common stock
    168       -       -       -       -       168  
Parent investment
    -       51,889       43,167       58,480       (153,536 )     -  
Additional paid-in capital
    74,789       -       -       (211 )     211       74,789  
Accumulated other comprehensive loss
    (1,725 )     (1,725 )     -       (872 )     2,597       (1,725 )
Retained earnings
    91,705       109,272       14,012       38,073       (161,357 )     91,705  
Treasury stock, at cost
    (2,800 )     -       -       -       -       (2,800 )
Total stockholders’ equity
    162,137       159,436       57,179       95,470       (312,085 )     162,137  
Total liabilities and stockholders' equity
  $ 200,973     $ 425,604     $ 64,875     $ 116,484     $ (339,658 )   $ 468,278  
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING BALANCE SHEET
As of October 3, 2008
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Assets
                                   
Current assets:
                                   
Cash and cash equivalents
  $ 84     $ 26,272     $ 493     $ 1,821     $ -     $ 28,670  
Restricted cash
    -       -       629       147       -       776  
Accounts receivable, net
    -       22,453       12,353       12,542       -       47,348  
Inventories
    -       42,066       6,759       17,653       (990 )     65,488  
Deferred tax assets
    -       10,853       2       556       -       11,411  
Intercompany receivable
    -       8,523       5,135       13,454       (27,112 )     -  
Prepaid and other current assets
    -       2,370       632       821       -       3,823  
Total current assets
    84       112,537       26,003       46,994       (28,102 )     157,516  
Property, plant and equipment, net
    -       45,556       3,047       13,884       -       62,487  
Deferred debt issue costs, net
    392       4,602       -       -       -       4,994  
Intangible assets, net
    -       56,700       14,168       7,666       -       78,534  
Goodwill
    -       93,375       20,973       48,263       -       162,611  
Other long-term assets
    -       383       287       136       -       806  
Intercompany notes receivable
    -       1,035       -       -       (1,035 )     -  
Investment in subsidiaries
    182,869       101,193       -       -       (284,062 )     -  
Total assets
  $ 183,345     $ 415,381     $ 64,478     $ 116,943     $ (313,199 )   $ 466,948  
                                                 
Liabilities and stockholders' equity
                                               
Current liabilities:
                                               
Current portion of long-term debt
  $ -     $ 1,000     $ -     $ -     $ -     $ 1,000  
Accounts payable
    272       10,893       2,116       7,828       -       21,109  
Accrued expenses
    186       14,905       3,143       4,810       -       23,044  
Product warranty
    -       2,002       538       1,619       -       4,159  
Income taxes payable
    -       1,280       213       6,273       -       7,766  
Advance payments from customers
    -       7,624       3,132       1,579       -       12,335  
Intercompany payable
    27,112       -       -       -       (27,112 )     -  
Total current liabilities
    27,570       37,704       9,142       22,109       (27,112 )     69,413  
Deferred income taxes
    -       21,922       -       5,399       -       27,321  
Intercompany notes payable
    -       -       -       1,035       (1,035 )     -  
Long-term debt, less current portion
    11,910       212,750       -       -       -       224,660  
Other long-term liabilities
    -       1,213       -       476       -       1,689  
Total liabilities
    39,480       273,589       9,142       29,019       (28,147 )     323,083  
Common stock
    165       -       -       -       -       165  
Parent investment
    -       50,020       43,167       58,114       (151,301 )     -  
Additional paid-in capital
    71,818       -       -       -       -       71,818  
Accumulated other comprehensive loss
    (1,809 )     (1,809 )     -       (283 )     2,092       (1,809 )
Retained earnings
    76,491       93,581       12,169       30,093       (135,843 )     76,491  
Treasury stock, at cost
    (2,800 )     -       -       -       -       (2,800 )
Total stockholders’ equity
    143,865       141,792       55,336       87,924       (285,052 )     143,865  
Total liabilities and stockholders' equity
  $ 183,345     $ 415,381     $ 64,478     $ 116,943     $ (313,199 )   $ 466,948  
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Three Months Ended July 3, 2009
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 53,852     $ 17,956     $ 30,481     $ (19,769 )   $ 82,520  
 Cost of sales
    -       38,936       14,826       24,379       (19,905 )     58,236  
 Gross profit
    -       14,916       3,130       6,102       136       24,284  
 Operating costs and expenses:
                                               
 Research and development
    -       881       -       1,850       -       2,731  
 Selling and marketing
    -       1,830       1,094       1,838       -       4,762  
 General and administrative
    -       2,690       805       1,571       -       5,066  
 Amortization of acquisition-related intangible assets
    -       387       152       152       -       691  
 Net loss on disposition of assets
    -       7       -       -       -       7  
 Total operating costs and expenses
    -       5,795       2,051       5,411       -       13,257  
 Operating income
    -       9,121       1,079       691       136       11,027  
 Interest expense, net
    237       3,955       -       12       -       4,204  
 Gain on debt extinguishment
    -       (51 )     -       -       -       (51 )
(Loss) income before income tax expenseand equity in income of subsidiaries
    (237 )     5,217       1,079       679       136       6,874  
 Income tax (benefit) expense
    (88 )     4,231       209       (1,348 )     -       3,004  
 Equity in income of subsidiaries
    4,019       3,033       -       -       (7,052 )     -  
 Net income
  $ 3,870     $ 4,019     $ 870     $ 2,027     $ (6,916 )   $ 3,870  

 
CONDENSED CONSOLIDATING STATEMENT OF INCOME
 For the Three Months Ended June 27, 2008
 

   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 56,694     $ 18,355     $ 34,492     $ (18,807 )   $ 90,734  
 Cost of sales
    -       39,343       15,562       27,127       (18,530 )     63,502  
 Gross profit
    -       17,351       2,793       7,365       (277 )     27,232  
 Operating costs and expenses:
                                               
   Research and development
    -       817       5       1,944       -       2,766  
   Selling and marketing
    -       1,838       1,000       2,174       -       5,012  
   General and administrative
    -       3,472       1,077       587       -       5,136  
 Amortization of acquisition-related intangible assets
    -       334       296       152       -       782  
   Net loss on disposition of fixed assets
    -       128       -       -       -       128  
 Total operating costs and expenses
    -       6,589       2,378       4,857       -       13,824  
 Operating income
    -       10,762       415       2,508       (277 )     13,408  
   Interest expense (income), net
    357       4,266       (10 )     14       -       4,627  
   Loss on debt extinguishment
    121       -       -       -       -       121  
(Loss) income before income tax expense and equity in income of subsidiaries
    (478 )     6,496       425       2,494       (277 )     8,660  
   Income tax (benefit) expense
    (181 )     2,592       106       319       -       2,836  
   Equity in income of subsidiaries
    6,121       2,217       -       -       (8,338 )     -  
 Net income
  $ 5,824     $ 6,121     $ 319     $ 2,175     $ (8,615 )   $ 5,824  
                                                 
 
 
 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)

 
CONDENSED CONSOLIDATING STATEMENT OF INCOME
 For the Nine Months Ended July 3, 2009
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 152,707     $ 54,740     $ 92,714     $ (58,592 )   $ 241,569  
 Cost of sales
    -       115,000       45,563       73,690       (58,650 )     175,603  
 Gross profit
    -       37,707       9,177       19,024       58       65,966  
 Operating costs and expenses:
                                               
 Research and development
    -       2,639       3       5,429       -       8,071  
 Selling and marketing
    -       5,392       3,329       5,831       -       14,552  
 General and administrative
    -       10,584       2,959       1,923       -       15,466  
 Amortization of acquisition-related intangible assets
    -       1,167       456       453       -       2,076  
 Net loss on disposition of assets
    -       64       -       7       -       71  
 Total operating costs and expenses
    -       19,846       6,747       13,643       -       40,236  
 Operating income
    -       17,861       2,430       5,381       58       25,730  
 Interest expense (income), net
    768       12,153       (8 )     52       -       12,965  
 Gain on debt extinguishment
    -       (248 )     -       -       -       (248 )
(Loss) income before income tax expense and equity in income of subsidiaries
    (768 )     5,956       2,438       5,329       58       13,013  
 Income tax (benefit) expense
    (291 )     146       595       (2,651 )     -       (2,201 )
 Equity in income of subsidiaries
    15,691       9,881       -       -       (25,572 )     -  
 Net income
  $ 15,214     $ 15,691     $ 1,843     $ 7,980     $ (25,514 )   $ 15,214  
 
 

CONDENSED CONSOLIDATING STATEMENT OF INCOME
 For the Nine Months Ended June 27, 2008
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
 Sales
  $ -     $ 166,793     $ 59,306     $ 103,820     $ (58,471 )   $ 271,448  
 Cost of sales
    -       119,652       50,038       80,433       (58,109 )     192,014  
 Gross profit
    -       47,141       9,268       23,387       (362 )     79,434  
 Operating costs and expenses:
                                               
 Research and development
    -       2,438       426       5,556       -       8,420  
 Selling and marketing
    -       5,831       3,187       6,494       -       15,512  
 General and administrative
    -       11,007       3,165       2,609       -       16,781  
   Amortization of acquisition-related intangible assets     -       1,002       889       453       -       2,344  
 Net loss on disposition of fixed assets
    -       172       12       19       -       203  
 Total operating costs and expenses
    -       20,450       7,679       15,131       -       43,260  
 Operating income
    -       26,691       1,589       8,256       (362 )     36,174  
 Interest expense (income), net
    1,414       12,865       (47 )     12       -       14,244  
 Loss on debt extinguishment
    514       -       -       -       -       514  
(Loss) income before income tax expense and equity in income of subsidiaries
    (1,928 )     13,826       1,636       8,244       (362 )     21,416  
 Income tax (benefit) expense
    (732 )     6,074       225       1,361       -       6,928  
 Equity in income of subsidiaries
    15,684       7,932       -       -       (23,616 )     -  
 Net income
  $ 14,488     $ 15,684     $ 1,411     $ 6,883     $ (23,978 )   $ 14,488  
 

 
 
CPI INTERNATIONAL, INC.
and Subsidiaries
 
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(All tabular dollar amounts in thousands except share and per share amounts)


 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended July 3, 2009
 

   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Cash flows from operating activities
                                   
Net cash (used in) provided by operating activities
  $ (1,266 )   $ 19,527     $ 423     $ 1,624     $ -     $ 20,308  
Cash flows from investing activities
                                               
Capital expenditures
    -       (2,053 )     (215 )     (81 )     -       (2,349 )
Net cash used in investing activities
    -       (2,053 )     (215 )     (81 )     -       (2,349 )
Cash flows from financing activities
                                               
Repayments of debt
    -       (12,358 )     -       -       -       (12,358 )
Proceeds from issuance of common stock to employees
  781       -       -       -       -       781  
Proceeds from exercise of stock options
    82       -       -       -       -       82  
Excess tax benefit on stock option exercises
    -       51       -       -       -       51  
Intercompany dividends / loan repayments
    396       (8,607 )     -       8,211       -       -  
Net cash provided by (used in) financing activities
    1,259       (20,914 )     -       8,211       -       (11,444 )
Net (decrease) increase in cash and cash equivalents
    (7 )     (3,440 )     208       9,754       -       6,515  
Cash and cash equivalents at beginning of period
    84       26,272       493       1,821       -       28,670  
Cash and cash equivalents at end of period
  $ 77     $ 22,832     $ 701     $ 11,575     $ -     $ 35,185  

 
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Nine Months Ended June 27, 2008
 
 
   
Parent
   
Issuer
   
Guarantor
   
Non-Guarantor
   
Consolidating
   
Consolidated
 
   
(CPI Int'l)
   
(CPI)
   
Subsidiaries
   
Subsidiaries
   
Eliminations
   
Total
 
Cash flows from operating activities
                                   
Net cash (used in) provided by operating activities
  $ (2,127 )   $ 25,560     $ 271     $ 995     $ -     $ 24,699  
Cash flows from investing activities
                                               
Capital expenditures
    -       (2,467 )     (223 )     (598 )     -       (3,288 )
Proceeds from adjustment to acquisition purchase price
  -       1,615       -       -       -       1,615  
Payment of patent application fees
    -       -       (147 )     -       -       (147 )
Net cash used in investing activities
    -       (852 )     (370 )     (598 )     -       (1,820 )
Cash flows from financing activities
                                               
Purchases of treasury stock
    (1,800 )     -       -       -       -       (1,800 )
Repayments of debt
    (8,000 )     (8,000 )     -       -       -       (16,000 )
Proceeds from issuance of common stock to employees
  639       -       -       -       -       639  
Proceeds from exercise of stock options
    3       -       -       -       -       3  
Excess tax benefit on stock option exercises
    -       2       -       -       -       2  
Intercompany dividends
    10,100       (10,100 )     -       -       -       -  
Net cash provided by (used in) financing activities
    942       (18,098 )     -       -       -       (17,156 )
Net (decrease) increase in cash and cash equivalents
    (1,185 )     6,610       (99 )     397       -       5,723  
Cash and cash equivalents at beginning of period
    1,378       16,518       958       1,620       -       20,474  
Cash and cash equivalents at end of period
  $ 193     $ 23,128     $ 859     $ 2,017     $ -     $ 26,197  
 
 
 
 
 
Item 2.              Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Our fiscal years are the 52- or 53-week periods that end on the Friday nearest September 30. Fiscal year 2009 comprises the 52-week period ending October 2, 2009, and fiscal year 2008 comprised the 53-week period ended October 3, 2008. The third quarters of both fiscal years 2009 and 2008 include 13 weeks. The first three quarters of both fiscal years 2009 and 2008 include 39 weeks. The following discussion should be read in conjunction with the accompanying unaudited condensed consolidated financial statements, and the notes thereto, of CPI International, Inc.
 
 
Overview
 
CPI International, Inc., headquartered in Palo Alto, California, is the parent company of Communications & Power Industries, a provider of microwave, radio frequency, power and control solutions for critical defense, communications, medical, scientific and other applications. Communications & Power Industries develops, manufactures and distributes products used to generate, amplify and transmit high-power/high-frequency microwave and radio frequency signals and/or provide power and control for various applications. End-use applications of these systems include the transmission of radar signals for navigation and location; transmission of deception signals for electronic countermeasures; transmission and amplification of voice, data and video signals for broadcasting, Internet and other types of commercial and military communications; providing power and control for medical diagnostic imaging; and generating microwave energy for radiation therapy in the treatment of cancer and for various industrial and scientific applications.
 
Unless the context otherwise requires, “CPI International” means CPI International, Inc., and “CPI” means Communications & Power Industries, Inc. CPI is a direct subsidiary of CPI International. CPI International is a holding company with no operations of its own. The terms “we,” “us,” “our” and the “Company” refer to CPI International and its direct and indirect subsidiaries on a consolidated basis.
 
Orders
 
We sell our products into five end markets: radar and electronic warfare, medical, communications, industrial and scientific.

Our customer sales contracts are recorded as orders when we accept written customer purchase orders or contracts. Customer purchase orders with an undefined delivery schedule, or blanket purchase orders, are not reported as orders until the delivery date is determined. Our government sales contracts are not reported as orders until we have been notified that the contract has been funded. Total orders for a fiscal period represent the total dollar amount of customer orders recorded by us during the fiscal period, reduced by the dollar amount of any order cancellations or terminations during the fiscal period.


 
 

Our orders by market for the nine months ended July 3, 2009 and June 27, 2008 are summarized as follows (dollars in millions):
 
   
Nine Months Ended
             
   
July 3, 2009
   
June 27, 2008
   
Increase (Decrease)
 
         
% of
         
% of
             
   
Amount
   
Orders
   
Amount
   
Orders
   
Amount
   
Percent
 
Radar and Electronic Warfare
  $ 113.0       42 %   $ 105.2       38 %   $ 7.8       7 %
Medical
    49.5       18       48.3       17       1.2       2  
Communications
    91.0       33       96.9       35       (5.9 )     (6 )
Industrial
    15.9       6       19.8       7       (3.9 )     (20 )
Scientific
    1.9       1       9.7       3       (7.8 )     (80 )
Total
  $ 271.3       100 %   $ 279.9       100 %   $ (8.6 )     (3 ) %

In the fourth quarter of fiscal year 2008, we changed the way in which we categorize orders and sales of the tactical common data link (“TCDL”) products at our Malibu division, which we acquired in August 2007. TCDL products support intelligence, surveillance and reconnaissance (“ISR”) applications. Previously, orders and sales of our TCDL products were included in our radar and electronic warfare market. We are now reporting these orders and sales in our communications market, which we believe is the more appropriate category for these products. We reclassified previously reported orders and sales information to properly reflect TCDL products as an increase in the communications market and a corresponding decrease in the radar and electronic warfare market. For the nine months ended June 27, 2008, the order amount reclassified was $4.1 million. The table above reflects this change.

Our commercial markets, which include our medical, commercial communications, industrial and scientific markets, were negatively impacted in the nine months ended July 3, 2009 by the weakening of the U.S. and foreign economies. Many of the commercial programs in which we participate depend on customers upgrading their current equipment or expanding their infrastructures. With the softening of global economies, we believe that many of our customers have delayed, reduced or cancelled their upgrade or expansion plans. We believe that the weak global economies have resulted in a near-term decrease in demand for our products to support commercial programs.
 
Orders of $271.3 million for the nine months ended July 3, 2009 were $8.6 million, or approximately 3%, lower than orders of $279.9 million for the corresponding period of fiscal year 2008. Explanations for the order increase or decrease by market are as follows:
 
·  
Radar and Electronic Warfare: The majority of our orders in the radar and electronic warfare markets are products for domestic and international defense and government end uses. Orders in these markets are characterized by many smaller orders in the $0.5 million to $3.0 million range by product or program, and the timing of the receipt of these orders may vary from year to year. On a combined basis, orders for the radar and electronic warfare markets increased approximately 7% from an aggregate of $105.2 million in the nine months ended June 27, 2008 to an aggregate of $113.0 million in the nine months ended July 3, 2009. The increase in orders for these combined markets resulted primarily from the timing of the placement of orders to support various domestic and foreign electronic warfare programs, as well as the receipt of several large development orders to support various radar programs, and was partially offset by a decrease in demand for products to support certain other radar programs.
 

 
 

·  
Medical: Orders for our medical products consist of orders for medical imaging applications, such as x-ray imaging, magnetic resonance imaging (“MRI”), and positron emission tomography (“PET”) applications, and for radiation therapy applications for the treatment of cancer. The 2% increase in medical orders was due to increased demand for products to support MRI and radiation therapy applications. This increase was partially offset by a decrease in demand for products to support x-ray imaging applications due to the weakness of global economies.
 
·  
Communications: Orders for our communications products consist of orders for commercial communications applications and military communications applications. The 6% decrease in communications orders was primarily attributable to decreases in orders to support commercial communications applications, including direct-to-home broadcast, fixed satellite broadcast and satellite news gathering applications, as well as commercial radio broadcast applications. We believe that these decreases were largely due to the weakness of global economies. Delays in the timing of orders received by our Malibu division also contributed to the decrease in communications orders. These decreases were partially offset by an increase in orders for military communications programs, including a $12.5 million increase in orders for the Warfighter Information Network – Tactical (WIN-T) program due to order timing for that program. Military communications is a relatively new sector of the overall communications market for us. We expect our participation in military communications programs to continue to grow.
 
·  
Industrial: Orders in the industrial market are cyclical and are generally tied to the state of the economy. The $3.9 million decrease in industrial orders was attributable to decreases in orders for products used in a wide variety of industrial applications, including semiconductor wafer fabrication and industrial heating and processing applications.
 
·  
Scientific: Orders in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $7.8 million decrease in scientific orders was primarily the result of the receipt of a multi-year $5.6 million order in the first nine months of fiscal year 2008 for products to support a new accelerator project for fusion research at an international scientific institute. This order was not expected to, and did not, repeat in the first nine months of fiscal year 2009; shipments for this order are scheduled to be completed in fiscal year 2011.
 
Incoming order levels can fluctuate significantly on a quarterly or annual basis, and a particular quarter’s or year’s order rate may not be indicative of future order levels. In addition, our sales are highly dependent upon manufacturing scheduling and performance and, accordingly, it is not possible to accurately predict when orders will be recognized as sales.
 
Backlog

As of July 3, 2009, we had an order backlog of $232.1 million compared to an order backlog of $205.8 million as of June 27, 2008. Because our orders for government end-use products generally have much longer delivery terms than our orders for commercial business (which require quicker turn-around), our backlog is primarily composed of government orders.


 
 

Backlog represents the cumulative balance, at a given point in time, of recorded customer sales orders that have not yet been shipped or recognized as sales. Backlog is increased when an order is received, and backlog is decreased when we recognize sales. We believe that backlog and orders information is helpful to investors because this information may be indicative of future sales results. Although backlog consists of firm orders for which goods and services are yet to be provided, customers can, and sometimes do, terminate or modify these orders. However, historically the amount of modifications and terminations has not been material compared to total contract volume.

Results of Operations
 
We derive our revenue primarily from the sale of microwave and radio frequency products, including high-power microwave amplifiers, satellite communications amplifiers, medical x-ray imaging subsystems and other related products. Our products generally have selling prices ranging from $2,000 to $100,000, with certain limited products priced up to $1,000,000.
 
Cost of goods sold generally includes costs for raw materials, manufacturing costs, including allocation of overhead and other indirect costs, charges for reserves for excess and obsolete inventory, warranty claims and losses on fixed price contracts. Operating expenses generally consist of research and development, selling and marketing and general and administrative expenses.
 
Three Months Ended July 3, 2009 Compared to Three Months Ended June 27, 2008
 
The following table sets forth our historical results of operations for each of the periods indicated (dollars in millions):
 

   
Three Months Ended
       
   
July 3,
2009
   
June 27,
2008
   
Increase
(Decrease)
 
         
% of
         
% of
       
   
Amount
   
Sales
   
Amount
   
Sales
   
Amount
 
Sales
  $ 82.5       100.0 %   $ 90.7       100.0 %   $ (8.2 )
Cost of sales
    58.2       70.5       63.5       70.0       (5.3 )
Gross profit
    24.3       29.5       27.2       30.0       (2.9 )
Research and development
    2.7       3.3       2.8       3.1       (0.1 )
Selling and marketing
    4.8       5.8       5.0       5.5       (0.2 )
General and administrative
    5.1       6.2       5.1       5.6       -  
Amortization of acquisition-related intangibles
    0.7       0.8       0.8       0.9       (0.1 )
Net loss on disposition of assets
    -       -       0.1       -       (0.1 )
Operating income
    11.0       13.3       13.4       14.8       (2.4 )
Interest expense, net
    4.2       5.1       4.6       5.1       (0.4 )
(Gain) loss on debt extinguishment
    (0.1 )     (0.1 )     0.1       0.1       (0.2 )
Income before taxes
    6.9       8.4       8.7       9.6       (1.8 )
Income tax expense
    3.0       3.6       2.8       3.1       0.2  
Net income
  $ 3.9       4.7 %   $ 5.8       6.4 %   $ (1.9 )
Other Data:
                                       
EBITDA (a)
  $ 13.8       16.7 %   $ 16.1       17.8 %   $ (2.3 )
 
   
Note:  Totals may not equal the sum of the component line items due to independent rounding. Percentages are calculated based on rounded dollar amounts presented.
 

 
 

(a)   
EBITDA represents earnings before net interest expense, provision for income taxes and depreciation and amortization. For the reasons listed below, we believe that GAAP-based financial information for leveraged businesses such as ours should be supplemented by EBITDA so that investors better understand our financial  performance in nnection with their analysis of our business:
 
 
EBITDA is a component of the measures used by our board of directors and management team to evaluate our operating performance;
 
 
our senior credit facilities contain a covenant that requires us to maintain a senior secured leverage ratio that contains EBITDA as a component, and our management team uses EBITDA to monitor compliance with this covenant;
 
 
EBITDA is a component of the measures used by our management team to make day-to-day operating decisions;
 
 
EBITDA facilitates comparisons between our operating results and those of competitors with different capital structures and therefore is a component of the measures used by the management to facilitate internal comparisons to competitors' results and our industry in general; and
 
 
the payment of management bonuses is contingent upon, among other things, the satisfaction by us of certain targets that contain EBITDA as a component.
 
 
Other companies may define EBITDA differently and, as a result, our measure of EBITDA may not be directly comparable to EBITDA of other companies. Although we use EBITDA as a financial measure to assess the performance of our business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate our business. When analyzing our performance, EBITDA should be considered in addition to, and not as a substitute for, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP.
 
 
For a reconciliation of Net Income to EBITDA, see Note 11 of the accompanying unaudited condensed consolidated financial statements.
 
 
Sales: Our sales by market for the three months ended July 3, 2009 and June 27, 2008 are summarized as follows (dollars in millions):
 
   
Three Months Ended
             
   
July 3, 2009
   
June 27, 2008
   
Increase (Decrease)
 
         
% of
         
% of
             
   
Amount
   
Sales
   
Amount
   
Sales
   
Amount
   
Percent
 
Radar and Electronic Warfare
  $ 35.7       43 %   $ 38.0       42 %   $ (2.3 )     (6 ) %
Medical
    15.5       19       16.8       19       (1.3 )     (7 )
Communications
    24.0       29       28.2       31       (4.2 )     (15 )
Industrial
    5.9       7       5.8       6       0.1       2  
Scientific
    1.4       2       1.9       2       (0.5 )     (28 )
Total
  $ 82.5       100 %   $ 90.7       100 %   $ (8.2 )     (9 ) %

In the fourth quarter of fiscal year 2008, we changed the way in which we categorize orders and sales of the TCDL products at our Malibu division. Previously, orders and sales of our TCDL products were included in our radar and electronic warfare market. We are now reporting these orders and sales in our communications market, which we believe is the more appropriate category for these products. We reclassified previously reported orders and sales information to properly reflect TCDL products as an increase in the communications market and a corresponding decrease in the radar and electronic warfare market. For the three months ended June 27, 2008, the sales amount reclassified was $0.2 million. The table above reflects this change.

In recent quarters, our defense markets, which include our radar and electronic warfare markets, have been negatively impacted by delays in the receipt of orders, causing delays in the subsequent shipments of products and having a negative effect on our near-term defense sales. We believe the order levels in our defense markets are currently stabilizing, but delays in the receipt of orders and the corresponding sales for certain defense programs may continue for the foreseeable future.
 
 
 
 
 
Sales of $82.5 million for the three months ended July 3, 2009 were $8.2 million, or approximately 9%, lower than sales of $90.7 million for the corresponding period of fiscal year 2008. Explanations for the sales increase or decrease by market are as follows:

·  
Radar and Electronic Warfare: The majority of our sales in the radar and electronic warfare markets are products for domestic and international defense and government end uses. The timing of the receipt of orders and subsequent shipments in these markets may vary from year to year. On a combined basis, sales for these two markets decreased approximately 6% from $38.0 million in the three months ended June 27, 2008 to $35.7 million in the three months ended July 3, 2009, primarily due to an expected $2.3 million decrease in shipments of products to support the Aegis weapons system and decreases in sales for several other radar programs due to the timing of order receipts for those programs. These decreases were partially offset by the shipment of products from development programs to support radar applications.
 
Demand for our products to support ships with the Aegis weapons system has two components: we support new ship builds and we provide spare and repair products for previously fielded ships. Over the past several years, we have seen high demand for products to support a significant number of funded new ship builds for the Aegis weapons program for U.S. and international military customers. We have now completed supplying our products required to support these funded new ship builds, and, as a result, we expect the near-term demand to be primarily for spare and repair products and the near-term sales to be roughly half of the approximately $20 million fiscal year 2008 sales level. We expect demand for our products to increase again in several years as the new ships are commissioned, deployed and added to the installed base, after which they also will require spare and repair products.
 
·  
Medical: Sales of our medical products consist of sales for medical imaging applications, such as x-ray imaging, MRI and PET applications, and for radiation therapy applications for the treatment of cancer. The 7% decrease in medical product sales was due to decreased sales of x-ray imaging products to international customers as a result of the weakness of global economies.
 
·  
Communications: Sales of our communications products consist of sales for commercial communications applications and military communications applications. The 15% decrease in sales in the communications market was primarily attributable to decreases in sales to support certain commercial communications applications, including satellite news gathering and direct-to-home broadcast applications. We believe the decreases were largely due to the weakness of global economies. These decreases were partially offset by an increase in sales of products for military communications programs, which is a relatively new sector of the overall communications market for us. We expect our participation in military communications programs to continue to grow.
 
·  
Industrial: Sales in the industrial market are cyclical and are generally tied to the state of the economy. Industrial sales were essentially unchanged. A decrease in sales of industrial products, primarily attributable to decreases in orders for products used in industrial fabrication applications, including semiconductor wafer fabrication, and industrial heating applications, was offset by an increase in sales of electromagnetic susceptibility testing systems.
 

 
 

·  
Scientific: Sales in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $0.5 million decrease in scientific sales was primarily the result of the timing of certain scientific programs.
 
Gross Profit. Gross profit was $24.3 million, or 29.5% of sales, for the three months ended July 3, 2009, a $2.9 million decrease from the $27.2 million, or 30.0% of sales, for the three months ended June 27, 2008. Gross profit is influenced by numerous factors including sales volume and mix, pricing, raw material and manufacturing costs, and warranty costs. The primary reason for the reduction in gross profit for the three months ended July 3, 2009 as compared to the three months ended June 27, 2008 was lower sales volume and therefore lower manufacturing cost absorption due to the reduction in sales volume, partially offset by improved gross margins at our Malibu division and lower expenses from cost-reduction initiatives for the three months ended July 3, 2009.
 
Research and Development. Research and development expenses were $2.7 million, or 3.3% of sales, for the three months ended July 3, 2009, a $0.1 million decrease from $2.8 million, or 3.1% of sales, for the three months ended June 27, 2008.
 
Total spending on research and development, including customer-sponsored research and development, was as follows (in millions):

   
Three Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Company sponsored
  $ 2.7     $ 2.8  
Customer sponsored, charged to cost of sales
    4.8       2.2  
    $ 7.5     $ 5.0  

Selling and Marketing. Selling and marketing expenses were $4.8 million, or 5.8% of sales, for the three months ended July 3, 2009, a $0.2 million decrease from the $5.0 million, or 5.5% of sales, for the three months ended June 27, 2008. The reduction in selling and marketing expenses for the three months ended July 3, 2009 compared to the three months ended June 27, 2008 was primarily due to the favorable impact from currency translation of our foreign-based expenses and lower expenses from cost-reduction initiatives for the three months ended July 3, 2009.
 
General and Administrative. General and administrative expenses were $5.1 million, or 6.2% of sales, for the three months ended July 3, 2009, were unchanged from the $5.1 million, or 5.6% of sales, for the three months ended June 27, 2008.
 
Amortization of Acquisition-Related Intangibles. Amortization of acquisition-related intangibles consists of purchase accounting charges for technology and other intangible assets. Amortization of acquisition-related intangibles was $0.7 million for the three months ended July 3, 2009 and $0.8 million for the three months ended June 27, 2008. The $0.1 million dollar decrease in amortization of acquisition-related intangibles for the three months ended July 3, 2009 compared to the three months ended June 27, 2008 was primarily due to completed amortization of customer backlog in fiscal year 2008 for our Malibu division which was acquired in August 2007.
 

 
 

Interest Expense, net (“Interest Expense”). Interest Expense was $4.2 million, or 5.1% of sales, for the three months ended July 3, 2009, a $0.4 million decrease from the $4.6 million, or 5.1% of sales, for the three months ended June 27, 2008. The reduction in interest expense for the three months ended July 3, 2009 was primarily due to repayments and repurchases of debt over the past year which resulted in lower interest expense during the three months ended July 3, 2009 compared to the three months ended June 27, 2008.
 
(Gain) Loss on Debt Extinguishment. The gain on debt extinguishment of $0.1 million in the three months ended July 3, 2009 resulted from the repurchase of $5.0 million of our 8% senior subordinated notes at a discount of $138,000, or 2.75% of par value, partially offset by an $86,000 non-cash write-off of deferred debt issue costs. The loss on debt extinguishment of $0.1 million in the three months ended June 27, 2008 resulted from the early redemption of $2.0 million of our floating rate senior notes in June 2008, consisting of $84,000 in non-cash write-offs of deferred debt issue costs and issue discount costs and $37,000 in cash payments for call premiums.
 
Income Tax Expense. We recorded an income tax expense of $3.0 million for the three months ended July 3, 2009 and an income tax expense of $2.8 million for the three months ended June 27, 2008. Our effective tax rate was approximately 44% for the three months ended July 3, 2009 as compared to approximately 33% for the three months ended June 27, 2008.
 
Income tax expense for the three months ended July 3, 2009 includes approximately $0.2 million of several non-recurring discrete income tax expenses and $0.2 million from foreign currency translation losses primarily from Canadian tax accounts, which, in aggregate, increased the quarterly effective rate by 6%.
 
Net Income. Net income was $3.9 million, or 4.7% of sales, for the three months ended July 3, 2009 as compared to $5.8 million, or 6.4% of sales, in the three months ended June 27, 2008. The $1.9 million decrease in net income for the three months ended July 3, 2009 as compared to the three months ended June 27, 2008 was primarily due to lower gross profit from the reduction in sales volume during the current quarter, partially offset by lower expenses from the implementation of cost-reduction initiatives and lower interest expense during the current quarter.
 
EBITDA. EBITDA was $13.8 million, or 16.7% of sales, for the three months ended July 3, 2009 as compared to $16.1 million, or 17.8% of sales, for the three months ended June 27, 2008. The $2.3 million decrease in EBITDA in the three months ended July 3, 2009 as compared to the three months ended June 27, 2008 was due primarily to lower gross profit from the reduction in sales volume, partially offset by lower expenses from the implementation of cost-reduction initiatives.
 

 
 

Nine Months Ended July 3, 2009 Compared to Nine Months Ended June 27, 2008
 
The following table sets forth our historical results of operations for each of the periods indicated (dollars in millions):
 
   
Nine Months Ended
       
   
July 3,
2009
   
June 27,
2008
   
Increase
(Decrease)
 
         
% of
         
% of
       
   
Amount
   
Sales
   
Amount
   
Sales
   
Amount
 
Sales
  $ 241.6       100.0 %   $ 271.4       100.0 %   $ (29.8 )
Cost of sales
    175.6       72.7       192.0       70.7       (16.4 )
Gross profit
    66.0       27.3       79.4       29.3       (13.4 )
Research and development
    8.1       3.4       8.4       3.1       (0.3 )
Selling and marketing
    14.6       6.0       15.5       5.7       (0.9 )
General and administrative
    15.5       6.4       16.8       6.2       (1.3 )
Amortization of acquisition-related intangibles
    2.1       0.9       2.3       0.8       (0.2 )
Net loss on disposition of assets
    0.1       0.0       0.2       0.1       (0.1 )
Operating income
    25.7       10.6       36.2       13.3       (10.5 )
Interest expense, net
    13.0       5.4       14.2       5.2       (1.2 )
(Gain) loss on debt extinguishment
    (0.2 )     (0.1 )     0.5       0.2       (0.7 )
Income before taxes
    13.0       5.4       21.4       7.9       (8.4 )
Income tax (benefit) expense
    (2.2 )     (0.9 )     6.9       2.5       (9.1 )
Net income
  $ 15.2       6.3 %   $ 14.5       5.3 %   $ 0.7  
Other Data:
                                       
EBITDA (a)
  $ 34.1       14.1 %   $ 43.8       16.1 %   $ (9.7 )
   
Note:  Totals may not equal the sum of the component line items due to independent rounding. Percentages are calculated based on rounded dollar amounts presented.
 
(a)   
EBITDA represents earnings before net interest expense, provision for income taxes and depreciation and amortization. For the reasons listed below, we believe that GAAP-based financial information for leveraged businesses such as ours should be supplemented by EBITDA so that investors better understand our financial  performance in nnection with their analysis of our business:
 
 
EBITDA is a component of the measures used by our board of directors and management team to evaluate our operating performance;
 
 
our senior credit facilities contain a covenant that requires us to maintain a senior secured leverage ratio that contains EBITDA as a component, and our management team uses EBITDA to monitor compliance with this covenant;
 
 
EBITDA is a component of the measures used by our management team to make day-to-day operating decisions;
 
 
EBITDA facilitates comparisons between our operating results and those of competitors with different capital structures and therefore is a component of the measures used by the management to facilitate internal comparisons to competitors' results and our industry in general; and
 
 
the payment of management bonuses is contingent upon, among other things, the satisfaction by us of certain targets that contain EBITDA as a component.
 
 
Other companies may define EBITDA differently and, as a result, our measure of EBITDA may not be directly comparable to EBITDA of other companies. Although we use EBITDA as a financial measure to assess the performance of our business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate our business. When analyzing our performance, EBITDA should be considered in addition to, and not as a substitute for, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP.
 
 
For a reconciliation of Net Income to EBITDA, see Note 11 of the accompanying unaudited condensed consolidated financial statements.
 
 
 
 
 
Sales. Our sales by market for the nine months ended July 3, 2009 and June 27, 2008 are summarized as follows (dollars in millions):
 
   
Nine Months Ended
             
   
July 3,
2009
   
June 27,
2008
   
Increase (Decrease)
 
         
% of
         
% of
             
   
Amount
   
Sales
   
Amount
   
Sales
   
Amount
   
Percent
 
Radar and Electronic Warfare
  $ 98.0       41 %   $ 111.6       41 %   $ (13.6 )     (12 ) %
Medical
    46.9       19       49.5       18       (2.6 )     (5 )
Communications
    75.5       31       85.0       31       (9.5 )     (11 )
Industrial
    15.8       7       17.9       7       (2.1 )     (12 )
Scientific
    5.4       2       7.4       3       (2.0 )     (28 )
Total
  $ 241.6       100 %   $ 271.4       100 %   $ (29.8 )     (11 ) %
 
 
In the fourth quarter of fiscal year 2008, we changed the way in which we categorize orders and sales of the TCDL products at our Malibu division. Previously, orders and sales of our TCDL products were included in our radar and electronic warfare market. We are now reporting these orders and sales in our communications market, which we believe is the more appropriate category for these products. We reclassified previously reported orders and sales information to properly reflect TCDL products as an increase in the communications market and a corresponding decrease in the radar and electronic warfare market. For the nine months ended June 27, 2008, the sales amount reclassified was $2.5 million. The table above reflects this change.
 
In recent quarters, our defense markets, which include our radar and electronic warfare markets, have been negatively impacted by delays in the receipt of orders, causing delays in the subsequent shipments of products and having a negative effect on our near-term defense sales. We believe the order levels in our defense markets are currently stabilizing, but delays in the receipt of orders and the corresponding sales for certain defense programs may continue for the foreseeable future.
 
Sales of $241.6 million for the nine months ended July 3, 2009 were $29.8 million, or approximately 11%, lower than sales of $271.4 million for the corresponding period of fiscal year 2008. Explanations for the sales decrease by market are as follows:

·  
Radar and Electronic Warfare: The majority of our sales in the radar and electronic warfare markets are products for domestic and international defense and government end uses. The timing of the receipt of orders and subsequent shipments in these markets may vary from year to year. On a combined basis, sales for these two markets decreased approximately 12% from $111.6 million in the nine months ended June 27, 2008 to $98.0 million in the nine months ended July 3, 2009, primarily due to an expected $6.2 million decrease in shipments of products to support the Aegis weapons system and decreases in sales for several other radar and electronic warfare programs due to the timing of order receipts for those programs.
 

 
 

 
Demand for our products to support ships with the Aegis weapons system has two components: we support new ship builds and we provide spare and repair products for previously fielded ships. Over the past several years, we have seen high demand for products to support a significant number of funded new ship builds for the Aegis weapons program for U.S. and international military customers. We have now completed supplying our products required to support these funded new ship builds, and, as a result, we expect the near-term demand to be primarily for spare and repair products and the near-term sales to be roughly half of the approximately $20 million fiscal year 2008 sales level. We expect demand for our products to increase again in several years as the new ships are commissioned, deployed and added to the installed base, after which they also will require spare and repair products.
 
·  
Medical: Sales of our medical products consist of sales for medical imaging applications, such as x-ray imaging, MRI and PET applications, and for radiation therapy applications for the treatment of cancer. The 5% decrease in sales of our medical products was primarily due to decreased sales of x-ray imaging products to international customers as a result of the weakness of global economies. This decrease was partially offset by increased demand for products to support radiation therapy applications.
 
·  
Communications: Sales of our communications products consist of sales for commercial communications applications and military communications applications. The 11% decrease in sales in the communications market was primarily attributable to decreases in sales to support certain commercial communications applications, including direct-to-home broadcast and satellite news gathering applications. We believe the decreases were largely due to the weakness of global economies. These decreases were partially offset by an increase in sales of products for military communications programs, which is a relatively new sector of the overall communications market for us. We expect our participation in military communications programs to continue to grow.
 
·  
Industrial: Sales in the industrial market are cyclical and are generally tied to the state of the economy. The $2.1 million decrease in industrial sales was due to decreases in demand for products used in industrial fabrication applications, including semiconductor wafer fabrication, and a wide variety of other industrial applications.
 
·  
Scientific: Sales in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $2.0 million decrease in scientific sales was primarily the result of the timing of certain scientific programs as well as the recent completion of product shipments for the Spallation Neutron Source at Oakridge National Laboratory.
 
Gross Profit. Gross profit was $66.0 million, or 27.3% of sales, for the nine months ended July 3, 2009, a $13.4 million decrease from $79.4 million, or 29.3% of sales, in the nine months ended June 27, 2008. Gross profit is influenced by numerous factors including sales volume and mix, pricing, raw material and manufacturing costs, and warranty costs. The primary reason for the reduction in gross profit for the nine months ended July 3, 2009 as compared to the nine months ended June 27, 2008 was lower sales volume and therefore lower manufacturing cost absorption due to the reduction in sales volume, partially offset by improved gross margins at our Malibu division and lower expenses from cost-reduction initiatives for the nine months ended July 3, 2009.
 
Research and Development. Research and development expenses were $8.1 million, or 3.4% of sales, for the nine months ended July 3, 2009, a $0.3 million decrease from $8.4 million, or 3.1% of sales, for the nine months ended June 27, 2008.
 
 
 
 
 
Total spending on research and development, including customer-sponsored research and development, was as follows (in millions):
 
   
Nine Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Company sponsored
  $ 8.1     $ 8.4  
Customer sponsored, charged to cost of sales
    12.1       9.5  
    $ 20.2     $ 17.9  

Selling and Marketing. Selling and marketing expenses were $14.6 million, or 6.0% of sales, for the nine months ended July 3, 2009, a $0.9 million decrease from the $15.5 million, or 5.7% of sales, for the nine months ended June 27, 2008. The reduction in selling and marketing expenses for the nine months ended July 3, 2009 compared to the nine months ended June 27, 2008 was primarily due to the implementation of cost-reduction initiatives and the favorable impact from currency translation of our foreign-based expenses during the current year.
 
General and Administrative. General and administrative expenses were $15.5 million, or 6.4% of sales, for the nine months ended July 3, 2009, a $1.3 million decrease from the $16.8 million, or 6.2% of sales, for the nine months ended June 27, 2008. The decrease in general and administrative expenses in the nine months ended July 3, 2009 was primarily due to lower expenses related to the implementation of cost-reduction initiatives during the current year.
 
Amortization of Acquisition-Related Intangibles. Amortization of acquisition-related intangibles consists of purchase accounting charges for technology and other intangible assets. Amortization of acquisition-related intangibles was $2.1 million for the nine months ended July 3, 2009 and $2.3 million for the nine months ended June 27, 2008. The $0.2 million dollar decrease in amortization of acquisition-related intangibles for the nine months ended July 3, 2009 compared to the nine months ended June 27, 2008 was primarily due to completed amortization of customer backlog in fiscal year 2008 for our Malibu division which was acquired in August 2007.
 
Interest Expense, Net (“Interest Expense”). Interest Expense of $13.0 million for the nine months ended July 3, 2009 was $1.2 million lower than interest expense of $14.2 million for the nine months ended June 27, 2008. The reduction in interest expense for the nine months ended July 3, 2009 was primarily due to repayments of debt over the past year which resulted in lower interest expense during the nine months ended July 3, 2009 compared to the nine months ended June 27, 2008.
 
(Gain) Loss on Debt Extinguishment. The gain on debt extinguishment of $0.2 million in the nine months ended July 3, 2009 resulted from the repurchase of $8.0 million of our 8% senior subordinated notes at a discount of $0.4 million, partially offset by a $0.2 million non-cash write-off of deferred debt issue costs. The loss on debt extinguishment of $0.5 million in the nine months ended June 27, 2008 resulted from the early redemption of $6.0 million of our floating rate senior notes in March 2008 and $2.0 million in June 2008. The loss on debt extinguishment in the nine months ended June 27, 2008 consists of $0.3 million in non-cash write-offs of deferred debt issue costs and issue discount costs and cash payments of $0.2 million for call premiums.
 

 
 

Income Tax (Benefit) Expense. We recorded an income tax benefit of $2.2 million for the nine months ended July 3, 2009 and an income tax expense of $6.9 million for the nine months ended June 27, 2008. The nine months ended July 3, 2009 included several significant discrete tax benefits: (1) $5.1 million related to an outstanding audit by the Canada Revenue Agency (“CRA”), (2) $0.7 million related to certain provisions of the California Budget Act of 2008 signed on February 20, 2009, which will allow a taxpayer to elect an alternative method to attribute taxable income to California for tax years beginning on or after January 1, 2011, which resulted in a reduction to our deferred tax liability accounts, and (3) $0.9 million for adjustments to Canadian deferred tax accounts.
 
In December 2008, a new tax treaty protocol between Canada and the U.S. became effective. The new treaty requires mandatory arbitration for the resolution of double taxation disputes not settled through the competent authority process. As a result of this new treaty, our tax position on an outstanding audit by the CRA has become more favorable, and we reduced our tax contingency reserve in Canada by $3.0 million, and established an income tax receivable and recognized an income tax benefit in the U.S for $2.8 million; this tax benefit was partially offset by a related increase in deferred tax liabilities of $0.7 million.
 
The $0.9 million adjustment to Canadian deferred tax accounts includes a $0.6 million tax benefit to reflect the reduction to Canadian corporate income tax rates, and a $0.3 million tax benefit to correct the computation of certain deferred tax accounts. The $0.6 million adjustment should have been recorded in the first quarter of fiscal year 2008 rather than in the first quarter of fiscal year 2009 and the $0.3 adjustment million should have been recorded in several prior years’ financial results. These adjustments are deemed immaterial to our results of operations and financial condition in current periods as well as prior affected periods.
 
Income tax expense for the nine months ended June 27, 2008 includes a discrete tax benefit of approximately $0.4 million that was attributable to the fourth quarter of fiscal year 2007 relating to the correction of an immaterial error in the computation of the warranty expense tax deduction.
 
Our estimated effective income tax rate for the remainder of fiscal year 2009 is expected to be approximately 37% to 38%.
 
Net Income. Net income was $15.2 million, or 6.3% of sales, for the nine months ended July 3, 2009 as compared to $14.5 million, or 5.3% of sales, in the nine months ended June 27, 2008. The $0.7 million increase in net income in the nine months ended July 3, 2009 as compared to the nine months ended June 27, 2008 was primarily due to discrete income tax benefits, lower expenses from the implementation of cost-reduction initiatives and lower interest expense during the nine months ended July 3, 2009, partially offset by lower gross profit from the reduction in sales volume during the nine months ended July 3, 2009.
 
EBITDA. EBITDA was $34.1 million, or 14.1% of sales, for the nine months ended July 3, 2009 as compared to $43.8 million, or 16.1% of sales, for the nine months ended June 27, 2008. The $9.7 million decrease in EBITDA for the nine months ended July 3, 2009 as compared to the corresponding period of fiscal year 2008 was due primarily to lower gross profit from the reduction in sales volume, partially offset by lower expenses from the implementation of cost-reduction initiatives for nine months ended July 3, 2009.
 

 
 
 
Liquidity and Capital Resources
 
Overview
 
Our liquidity is affected by many factors, some of which are based on normal ongoing operations of our business and others that are related to uncertainties in the markets in which we compete and other global economic factors. We have historically financed, and intend to continue to finance, our capital and working capital requirements including debt service and internal growth, through a combination of cash flows from our operations and borrowings under our senior credit facilities. Our primary uses of cash are cost of sales, operating expenses, debt service and capital expenditures.
 
We believe that we have the financial resources to meet our business requirements, including capital expenditures and working capital requirements, for the next 12 months.
 
 
Cash and Working Capital
 
The following summarizes our cash and cash equivalents and working capital (in millions):
 
   
July 3,
   
October 3,
 
   
2009
   
2008
 
Cash and cash equivalents
  $ 35.2     $ 28.7  
Working capital
  $ 100.2     $ 88.1  

We invest cash balances in excess of operating requirements in overnight U.S. Government securities and money market accounts. In addition to the above cash and cash equivalents, we had restricted cash of $0.8 million as of July 3, 2009, consisting primarily of bank guarantees from customer advance payments to our international subsidiaries. The bank guarantees become unrestricted cash when performance under the sales contract is complete.
 
The significant factors underlying the net increase in cash and cash equivalents during the nine months ended July 3, 2009 were the net cash provided by our operating activities of $20.3 million and proceeds of $0.9 million from employee stock purchases and exercise of stock options, partially offset by senior term loan repayment of $4.75 million and senior subordinated notes repurchase of $7.6 million, net of $0.4 million discount, and capital expenditures of $2.3 million.
 
As of July 3, 2009, we had $213.0 million in total principal amount of debt outstanding, compared to $225.75 million as of October 3, 2008. As of July 3, 2009, we had borrowing availability of $54.4 million under the revolver under our senior credit facilities.
 
As more fully described below, our most significant debt covenant compliance requirement is maintaining a secured leverage ratio of 3.75:1. Our current secured leverage ratio is approximately 0.9:1. With this low secured leverage ratio, we do not anticipate any need to restructure our debt or reenter the capital markets until fiscal year 2011 when our Senior Credit Facilities will mature unless we refinance our 8% senior subordinated notes due 2012 prior to July 31, 2011.
 

 
 
 
Historical Operating, Investing and Financing Activities
 
In summary, our cash flows were as follows (in millions):
 
   
Nine Months Ended
 
   
July 3,
   
June 27,
 
   
2009
   
2008
 
Net cash provided by operating activities
  $ 20.3     $ 24.7  
Net cash used in investing activities
    (2.3 )     (1.8 )
Net cash used in financing activities
    (11.5 )     (17.2 )
Net increase in cash and cash equivalents
  $ 6.5     $ 5.7  

Operating Activities
 
During the nine months ended July 3, 2009 and June 27, 2008, we funded our operating activities through cash generated internally. Cash provided by operating activities is net income adjusted for certain non-cash items and changes to working capital items.
 
Net cash provided by operating activities of $20.3 million in the nine months ended July 3, 2009 was attributable to net income of $15.2 million, depreciation, amortization and other non-cash charges of $8.8 million, partially offset by $3.7 million net cash used for working capital. The primary working capital uses of cash in the nine months ended July 3, 2009 were the net change in income tax receivable and payable attributable to discrete tax benefits related to an outstanding audit by the Canada Revenue Agency , an increase in inventories and a decrease in accounts payable. The increase in inventories was primarily due to selective increases of certain work-in-progress and finished goods to meet anticipated customer delivery requirements. The decrease in accounts payable related primarily to the timing of vendor payments. These uses of cash were partially offset by a decrease in accounts receivable resulting primarily from decreased sales.
 
Net cash provided by operating activities of $24.7 million in the nine months ended June 27, 2008 was attributable to net income of $14.5 million, depreciation, amortization and other non-cash charges of $9.9 million, and $0.3 million cash provided by working capital items. The primary items providing cash from working capital in the nine months ended June 27, 2008 were for $4.2 million decrease in accounts receivable and the release of $1.0 million restricted cash, partially offset by $1.5 million of prepaid income tax and $1.0 million decreases in each of income tax payable, product warranty and accrued expenses. The decrease in accounts receivables resulted primarily from timing and improved collection of trade receivables. The reduction in income taxes payable was due to the timing of payments. The decrease in accrued expenses related primarily to the timing of payroll and employee vacations, combined with timing of interest payments on debt.
 

 
 
 
Investing Activities
 
Investing activities for the nine months ended July 3, 2009 consisted of $2.3 million capital expenditures.
 
Investing activities for the nine months ended June 27, 2008 of $1.8 million consisted primarily of $3.3 million capital expenditures and $0.1 million payment of patent application fees. The amount of cash used in investing activities was partially offset by cash received as a result of a $1.6 million adjustment to the purchase price of Malibu based on the actual working capital of Malibu as of the acquisition closing date.
 
Financing Activities
 
Net cash used in financing activities for the nine months ended July 3, 2009 consisted primarily of senior term loan repayment of $4.75 million and senior subordinated notes repurchase of $7.6 million, net of $0.4 million discount, partially offset by $0.9 million in proceeds from employee stock purchases and exercise of stock options.
 
Net cash used in financing activities for the nine months ended June 27, 2008 of $17.2 million consisted primarily of $1.8 million treasury stock purchases under the stock repurchase program discussed below, redemption of $8.0 million in principal amount of our floating rate senior notes and term loan repayments aggregating  $8.0 million. The cash used in financing activities for the nine months ended June 27, 2008 was partially offset by $0.6 million in proceeds from employee stock purchases.
 
If the leverage ratio under our amended and restated senior credit facilities exceeds 3.5:1 at the end of any fiscal year, then we are required to make an annual prepayment within 90 days after the end of the fiscal year based on a calculation of excess cash flow, as defined in the senior credit facilities, multiplied by a factor of 50%, less any optional prepayments made during the fiscal year. There was no excess cash flow payment due for fiscal year 2008, and, therefore, no excess cash flow payment was made in the nine months ended July 3, 2009.
 
Stock Repurchase Program

On May 28, 2008, we announced that our board of directors authorized us to implement a program to repurchase up to $12.0 million of our common stock from time to time in the 12 months following the announcement, funded entirely from cash on hand. The stock repurchase program has expired. Repurchases made under the program were subject to the terms and limitations of our debt covenants, as well as market conditions and share price, and were made at management's discretion in open market trades, through block trades or in privately negotiated transactions. During fiscal year 2008, we repurchased 206,243 shares at an average per share price of $13.54, plus average brokerage commissions of $0.04 per share, for an aggregate cost of $2.8 million. During the nine months ended July 3, 2009, we did not repurchase any shares of common stock under the program. Repurchased shares have been recorded as treasury shares and will be held until our board of directors designates that these shares be retired or used for other purposes.

 
 
 
Capital Expenditures
 
Our continuing operations typically do not have large recurring capital expenditure requirements. Capital expenditures are generally made to replace existing assets, increase productivity, facilitate cost reductions or meet regulatory requirements. Total capital expenditures for the nine months ended July 3, 2009 were $2.3 million. In the remainder of fiscal year 2009, ongoing capital expenditures are expected to be approximately $0.8 to $1.3 million.
 
 
Critical Accounting Policies and Estimates
 
Our consolidated financial statements are prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America, which require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon various factors and information available to us at the time that these estimates, judgments and assumptions are made. These factors and information may include, but are not limited to, history and prior experience, experience of other enterprises in the same industry, new related events, current economic conditions and information from third-party professionals. The estimates, judgments and assumptions we make can affect the reported amounts of  assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, our financial statements will be affected.
 
We believe the following critical accounting policies are the most significant to the presentation of our financial statements and require the most subjective and complex judgments. These matters, and the judgments and uncertainties affecting them, are also essential to understanding our reported and future operating results.
 
Revenue recognition
 
We generally recognize revenue upon shipment of product, following receipt of written purchase orders, when the price is fixed or determinable, title has transferred and collectibility is reasonably assured. Revenue recognized under the percentage of completion method of accounting is determined on the basis of costs incurred and estimates of costs at completion, which require management estimates of future costs. Changes in estimated costs at completion over time could have a material impact on our operating results.
 
Inventory reserves
 
We assess the valuation of inventory and periodically write down the value for estimated excess and obsolete inventory based upon actual usage and estimates about future demand. The excess balance determined by this analysis becomes the basis for our excess inventory charge. Management personnel play a key role in our excess inventory review process by providing updated sales forecasts, managing product rollovers and working with manufacturing to maximize recovery of excess inventory. If our estimates regarding demand are inaccurate or changes in technology affect demand for certain products in an unforeseen manner, we may incur losses or gains in excess of our established markdown reserve that could be material.
 

 
 
 
Management also reviews the carrying value of inventory for lower of cost or market on an individual product or contract basis. A loss reserve is charged to cost of sales if the estimated product cost or the contract cost at completion is in excess of net realizable value (selling price less estimated cost of disposal). If the actual contract cost at completion is different than originally estimated, then a loss or gain provision adjustment would be recorded that could have a material impact on our operating results.
 
Product warranty
 
Our products are generally warranted for a variety of periods, typically one to three years or a predetermined product usage life. A provision for estimated future costs of repair, replacement or customer accommodations is reflected in the consolidated condensed financial statements included in this report. We assess the adequacy of our preexisting warranty liabilities and adjust the balance based on actual experience and changes in future expectations. The determination of product warranty reserves requires us to make estimates of product return rates and expected cost to repair or replace the products under warranty. If actual repair and replacement costs differ significantly from our estimates, then adjustments to recognize additional cost of sales may be required.
 
Recoverability of long-lived assets
 
We account for goodwill and other intangible assets in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 142, "Goodwill and Other Intangible Assets." SFAS No. 142 requires that goodwill and identifiable intangible assets with indefinite useful lives be tested for impairment at least annually. SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives and reviewed for impairment in accordance with SFAS No. 144, "Accounting for the Impairment or Disposal of Long-Lived Assets." We amortize identifiable intangible assets on a straight-line basis over their useful lives of up to 50 years.
 
We assess the recoverability of the carrying value of goodwill and other intangible assets with indefinite useful lives at least annually or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. Recoverability of goodwill is measured at the reporting unit level (our six divisions) based on a two-step approach. First, the carrying amount of the reporting unit is compared to the fair value as estimated by the future net discounted cash flows expected to be generated by the reporting unit. To the extent that the carrying value of the reporting unit exceeds the fair value of the reporting unit, a second step is performed, wherein the reporting unit's assets and liabilities are valued. The implied fair value of goodwill is calculated as the fair value of the reporting unit in excess of the fair value of all non-goodwill assets and liabilities allocated to the reporting unit. To the extent the reporting unit's carrying value of goodwill exceeds its implied fair value, impairment exists and must be recognized. This process requires the use of discounted cash flow models that utilize estimates of future revenue and expenses as well as the selection of appropriate discount rates. There is inherent uncertainty in these estimates, and changes in these factors over time could result in an impairment charge.
 
At July 3, 2009 and October 3, 2008, the carrying amount of goodwill and other intangible assets, net was $238.5 million and $241.1 million, respectively. As of July 3, 2009, no significant changes in the underlying business assumptions or circumstances that drive the impairment analysis led us to believe that goodwill or other intangible assets might have been impaired. We will continue to evaluate the need for impairment if changes in circumstances or available information indicate that impairment may have occurred, and at least annually in the fourth quarter.
 

 
 

Our market capitalization has historically exceeded our net asset value, although recently it has been particularly volatile. Our market capitalization has dropped below our net asset value in certain days of the past few months largely, we believe, as a result of the recent global economic downturn and volatility in the financial markets. If our stock price would again fall below our net asset value per share, the decline in our market capitalization could trigger the requirement of performing the impairment test on goodwill, which could result in an impairment of our goodwill.

At July 3, 2009 and October 3, 2008, the carrying amount of property, plant and equipment was $58.9 million and $62.5 million, respectively. We assess the recoverability of property, plant and equipment to be held and used by a comparison of the carrying amount of an asset or group of assets to the future net undiscounted cash flows expected to be generated by the asset or group of assets. If such assets are considered impaired, then the impairment recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. This process requires the use of cash flow models that utilize estimates of future revenue and expenses. There is inherent uncertainty in these estimates, and changes in these factors over time could result in an impairment charge.
 
A prolonged general economic downturn and, specifically, a prolonged downturn in the defense, communications or medical markets, or technological changes, as well as other market factors could intensify competitive pricing pressure, create an imbalance of industry supply and demand, or otherwise diminish volumes or profits. Such events, combined with changes in interest rates, could adversely affect our estimates of future net cash flows to be generated by our long-lived assets. Consequently, it is possible that our future operating results could be materially and adversely affected by any impairment charges related to the recoverability of our long-lived assets.
 
Accounting for stock-based compensation
 
We account for stock-based compensation in accordance with SFAS No. 123 (revised 2004) or 123(R), "Share-Based Payment." Under the fair value recognition provisions of this statement, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period, which is generally the vesting period.
 
The fair value of each time-based option award is estimated on the date of grant using the Black-Scholes model. The fair value of each market performance-based (or combination of market performance- and time-based) option, restricted stock and restricted stock unit award is estimated on the date of grant using the Monte Carlo simulation technique in a risk-neutral framework. The Black-Scholes and the Monte Carlo simulation valuation models were developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable and require the input of subjective assumptions, including the expected stock price volatility and estimated option life. For purposes of these valuation models, no dividends have been assumed.
 

 
 
 
In accordance with SFAS No. 123(R), prior to becoming a public entity in April 2006, we used the minimum value method to determine a calculated value, rather than a fair value, of share awards. Under the minimum value method, stock price volatility was assumed to be zero. The estimated fair value (or calculated value, as applicable) of our stock-based awards, less expected forfeitures, is amortized over the awards' vesting period on a straight-line basis for awards granted after the adoption of SFAS No. 123(R). Since our common stock has not been publicly traded for a sufficient time period, the expected volatility is based on expected volatilities of similar companies that have a longer history of being publicly traded or a blend of our expected volatility based on available historical data and those of similar companies. The risk-free rates are based on the U.S. Treasury yield in effect at the time of the grant. Since our historical data is limited, the expected life of options granted is based on the simplified method for plain vanilla options in accordance with Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 107. In December 2007, the SEC issued SAB No. 110, an amendment of SAB No. 107. SAB No. 110 states that the staff will continue to accept, under certain circumstances, the continued use of the simplified method beyond December 31, 2007. Accordingly, we will continue to use the simplified method until we have enough historical experience to provide a reasonable estimate of expected term. For the three and nine months ended July 3, 2009, we recognized $0.7 million and $2.0 million, respectively, in stock-based compensation expense. For the three and nine months ended June 27, 2008, we recognized $0.6 million and $1.6 million, respectively, in stock-based compensation expense.
 
Income taxes
 
We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, tax benefits and deductions and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Significant changes to these estimates may result in an increase or decrease to our tax provision in a subsequent period.
 
We must assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not more likely than not, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that all of the deferred tax assets recorded on our consolidated balance sheets will ultimately be recovered. However, should there be a change in our ability to recover our deferred tax assets, our tax provision would increase in the period in which we determined that the recovery was not more likely than not.
 

 
 
 
In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. In the first quarter of fiscal year 2008, we adopted Financial Accounting Standards Board (“FASB”) Interpretation (“FIN”) No. 48 and related guidance. See Note 9 to consolidated condensed financial statements of this Form 10-Q for further discussion. FIN No. 48 requires that we recognize liabilities for uncertain tax positions based on the two-step process prescribed within the interpretation. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step requires us to estimate and measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires us to determine the probability of various possible outcomes. We reevaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.
 
 
Item 3.              Quantitative and Qualitative Disclosures About Market Risk
 
We do not use market risk sensitive instruments for trading or speculative purposes.
 
Interest rate risk
 
Our exposure to market risk for changes in interest rates relates primarily to our long-term debt. As of July 3, 2009, we had fixed rate senior subordinated notes of $117.0 million due in 2012, bearing interest at 8% per year and variable rate debt consisting of $12.0 million floating rate senior notes due in 2015 and a $84.0 million term loan under our amended and restated senior credit facilities due in 2014. Our variable rate debt is subject to changes in the prime rate and the LIBOR rate.

We use derivative instruments from time to time in order to manage interest costs and risk associated with our long-term debt. On September 21, 2007, we entered into an interest rate swap contract to receive three-month USD-LIBOR-BBA (British Bankers’ Association) interest and pay 4.77% fixed rate interest. Net interest positions are settled quarterly. We have structured the swap with decreasing notional amounts such that it is less than the balance of the term loan. The notional value of the swap was $55.0 million at July 3, 2009 and represented approximately 65% of the aggregate term loan balance. The swap agreement is effective through June 30, 2011. Under the provisions of SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities," as amended, this arrangement was initially designated and qualified as an effective cash flow hedge of interest rate risk related to the term loan under our senior credit facilities which permitted recording the fair value of the swap and corresponding unrealized gain or loss to accumulated other comprehensive income in the consolidated balance sheets. The interest rate swap gain or loss is included in the assessment of hedge effectiveness. At July 3, 2009, the fair value of the short-term and long-term portions of the swap was a liability of $1.9 million (accrued expenses) and $0.7 million (other long-term liabilities), respectively.
 
We performed a sensitivity analysis to assess the potential loss in future earnings that a 10% increase in the variable portion of interest rates over a one-year period would have on our floating rate senior notes and term loan under our senior credit facilities. The impact was determined based on the hypothetical change from the end of period market rates over a period of one year and results in an immaterial increase in future interest expense.
 

 
 
 
Foreign currency exchange risk
 
Although the majority of our revenue and expense activities are transacted in U.S. dollars, we do transact business in foreign countries. Our primary foreign currency cash flows are in Canada and several European countries. In an effort to reduce our foreign currency exposure to Canadian dollar denominated expenses, we enter into Canadian dollar forward contracts to hedge the Canadian dollar denominated costs for our manufacturing operation in Canada. Our Canadian dollar forward contracts are designated as a cash flow hedge and are considered highly effective, as defined by SFAS No. 133. The unrealized gains and losses from foreign exchange forward contracts are included in accumulated other comprehensive income in the consolidated balance sheets. If the transaction being hedged fails to occur, or if a portion of any derivative is ineffective, then we promptly recognize the gain or loss on the associated financial instrument in the consolidated statements of income. No ineffective amounts were recognized due to anticipated transactions failing to occur in the three and nine months ended July 3, 2009.
 
As of July 7, 2009, we had entered into Canadian dollar forward contracts for approximately $43.7 million (Canadian dollars), or approximately 77% of our estimated Canadian dollar denominated expenses for July 2009 through September 2010, at an average rate of approximately $0.85 U.S. dollar to Canadian dollar. We estimate the impact of a 1 cent change in the U.S. dollar to Canadian dollar exchange rate (without giving effect to our Canadian dollar forward contracts) to be approximately $0.3 million annually to our net income or approximately 2 cents to basic and diluted earnings per share.

At July 3, 2009, the fair value of foreign currency forward contracts was a short-term asset of $1.4 million (prepaid and other current assets) and a short-term liability of $0.5 million (accrued expenses).
 
 
Item 4.              Controls and Procedures
 
Management, including our principal executive officer and principal financial officer, has evaluated, as of the end of the period covered by this report, the effectiveness of the design and operation of our disclosure controls and procedures with respect to the information generated for use in this report. Based upon, and as of the date of that evaluation, the principal executive officer and principal financial officer concluded that the disclosure controls and procedures were effective to provide reasonable assurances that information required to be disclosed in the reports filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.
 
There have been no changes in our internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 

 
 


 
Part II:  OTHER INFORMATION
 
 
Item 1.              Legal Proceedings
 
None.
 
 
Item 1.A.      Risk Factors            
 
                   For a discussion of risk factors, see "Part I. Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended October 3, 2008. There have been no material changes from the risk factors disclosed in the "Risk Factors" section of our 2008 Form 10-K.
 
 
Item 2.              Unregistered Sales of Equity Securities and Use of Proceeds
 
   None.
 
 
Item 3.              Defaults Upon Senior Securities
 
   None.
 
 
Item 4.              Submission of Matters to a Vote of Security Holders
 
None.
 
 
Item 5.              Other Information
 
None.
 

 
 
 
Item 6.              Exhibits
 
No.
 
 
Description
  31.1  
Certification of Chief Executive Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e), promulgated under the Securities Exchange Act of 1934, as amended.
  31.2  
Certification of Chief Financial Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e), promulgated under the Securities Exchange Act of 1934, as amended.
  32.1  
Certifications of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2  
Certifications of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 

 
 

 
SIGNATURES
 
 

 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 

 
 
 
CPI INTERNATIONAL, INC.
 
 
 

 
Dated:August 12, 2009
/s/ JOEL A. LITTMAN
 
Joel A. Littman
Chief Financial Officer, Treasurer and Secretary
(Duly Authorized Officer and Chief Financial Officer)
 
 
 
- 68 -